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TOXICITY OF POTASSIUM BROMATE TO NUBIAN GOAT KIDS 
By 
HANAN MOHAMED NIEMTALLA GABRIL 
 
 
ABSTRACT 
        The present study was carried out to investigate the toxic effect of 
potassium bromate on Nubian goat kids. Twelve goat kids were divided into 
four groups A, B, C and D and treated with potassium bromate at doses of 0, 30, 
60 and 90 mg/kg body weight respectively for 6 weeks, when the toxin was 
withdrawn for a 4 weeks recovery period.  
          The mortality was 100% in goats treated with 90 mg/kg body weight 
potassium bromate and 33.3% in the group treated with 60 mg/kg body weight 
potassium bromate. Goats received 30 mg/kg body weight potassium bromate 
showed diarrhea, whereas dullness, weakness, nasal discharge, lacrimation, 
diarrhea, decreased appetite and temporary partial paralysis were observed in 
goats which received 60 mg/kg body weight potassium bromate. Recumbency, 
decreased urination, bloody urination, diarrhea, nasal discharge, lacrimation and 
decreased appetite were noticed in goats received 90 mg/kg body weight 
potassium bromate. Significant (p<0.05) weight loss was recorded in groups B 
and C. 
         There were significant (p>0.01) decreases in WBCs and RBCs values in 
all groups in the treatment period. Hb and PCV values were not significantly 
(p>0.01) changed in all groups. There were significant (p<0.01) decreases in 
MCHC values in the treatment period in groups C and D with significant 
(p<0.01) increases in the recovery period in groups B and C. In MCV values 
there were significant (p<0.01) increases in groups C and D in the treatment 
period and also significant (p<0.01) increases in group B and C in the recovery 
period. Urea and creatinine concentrations significantly (p>0.01) increased in 
group D. Total protein, albumin and globulin were significantly (p>0.01) 
increased in all groups. Uric acid was significantly (p>0.01) decreased in all 
groups. Sodium concentration was significantly (p>0.01) increased in group D. 
Phosphorous concentrations were significantly (p>0.01) increased in all groups. 
           The group which is treated with 90 mg potassium bromate /kg body 
weight showed congested intestines and enlargement of the gall bladder. 
Congestion and fatty degeneration in both the liver and kidney were seen in the 
both groups D and C treated with 90 and 60 mg/kg body weight potassium 
bromate respectively. 
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            Histopathological examination showed hepatocyte degeneration and 
necrosis in liver, congestion and swelling of tubular cells and desquamation of 
tubular epithelia in kidney and marked congestion and thickened interalobular 
septa in lungs in goats treated with 90 mg/kg body weight potassium bromate. In 
goats treated with 60 mg/kg body weight potassium bromate, cellular swelling 
and focal lymphocyte infilteration in liver, hypercellularity of glomerular tufts 
and dilated tubules in kidney and hemosiderosis in red pulp and distinct 
trabeculation in spleen were seen. In the group treated with 30 mg/kg potassium 
bromate the liver showed hepatic degeneration and leucocytes clumps mainly 
lymphocytes, in the kidney there were dilated tubules. Spleen showed prominent 
red pulp with germinal center. Intestine showed tapered villi, elongated glands 
and odema in submucosa.  
        Potassium bromate is considered a hepatonephric chemical toxicant to 
Nubian goat kids at the dose levels applied in the experiment.  
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 ﺳﻤﻴﺔ ﺑﺮوﻣﺎت اﻟﺒﻮﺗﺎﺳﻴﻮم ﻟﺠﺪﻳﺎن اﻟﻤﺎﻋﺰ اﻟﻨﻮﺑﻲ
 إﻋﺪاد
 ﺣﻨﺎن ﻣﺤﻤﺪ ﻧﻌﻤﺔ اﷲ ﺟﺒﺮﻳﻞ
 
 ﺧـــﻼﺻـﺔ
اﺳﺘﺨﺪم إﺛﻨﺎ ﻋﺸﺮ .  اﻟﻤﺎﻋﺰ اﻟﻨﻮﺑﻲﺛﺎر اﻟﺴﻤﻴﺔ ﻟﺒﺮوﻣﺎت اﻟﺒﻮﺗﺎﺳﻴﻮم ﻓﻲ ﺟﺪﻳﺎنأﺟﺮﻳﺖ هﺬﻩ اﻟﺪراﺳﺔ ﻟﻠﻜﺸﻒ ﻋﻦ اﻵ
آﺠﻢ / ﻣﻠﺠﻢ09 و06، 03ﻮﻳﺎت ﺻﻔﺮ، ﺑﺮوﻣﺎت اﻟﺒﻮﺗﺎﺳﻴﻮم ﺑﻤﺴﺘ   واﺟﺮﻋﺖد، ج، ب، أ  ﺟﺪﻳﺎ ﻗﺴﻤﺖ إﻟﻲ أرﺑﻊ ﻣﺠﻤﻮﻋﺎت
  .ﺳﺘﺔ أﺳﺎﺑﻴﻊ ﻗﺒﻞ ﺳﺤﺐ اﻟﺴﻢ ﻟﻤﺪة أرﺑﻌﺔ أﺳﺎﺑﻴﻊ ﻧﻘﺎهﺔ وزن ﺣﻲ ﻋﻠﻲ اﻟﺘﻮاﻟﻲ ﻟﻤﺪة
  
ﻓﻲ اﻟﻤﺠﻤﻮﻋﺔ اﻟﻤﺠﺮﻋﺔ ﺑـ % 3.33آﺠﻢ وزن ﺣﻲ و/ ﻣﻠﺠﻢ 09ﻓﻲ اﻟﻤﺠﻤﻮﻋﺔ اﻟﺘﻲ أﺟﺮﻋﺖ ﺑـ % 001آﺎن اﻟﻨﻔﻮق              
  ﺑﺮوﻣﺎت اﻟﺒﻮﺗﺎﺳﻴﻮم ﻣﻦآﺠﻢ وزن ﺣﻲ/ ﻣﻠﺠﻢ03ﻟﺠﺪﻳﺎن اﻟﻤﺠﺮﻋﺔ ﺑـأﻇﻬﺮت ا.  آﺠﻢ وزن ﺣﻲ/ ﻣﻠﺠﻢ ﺑﺮوﻣﺎت اﻟﺒﻮﺗﺎﺳﻴﻮم 06
ﺑﻴﻨﻤﺎ ﻇﻬﺮت أﻋﺮاض اﻟﺨﻤﻮل واﻟﻀﻌﻒ واﻹدﻣﺎع وﺳﻴﻼن اﻷﻧﻒ واﻹﺳﻬﺎل واﻟﺸﻬﻴﺔ اﻟﻤﺘﺪﻧﻴﺔ واﻟﺸﻠﻞ اﻟﺠﺰﺋﻲ اﻟﻤﺆﻗﺖ  إﺳﻬﺎًﻻ
آﺠﻢ وزن ﺣﻲ / ﻣﻠﺠﻢ09أﻇﻬﺮت اﻟﺠﺪﻳﺎن اﻟﻤﺠﺮﻋﺔ ﺑـ. آﺠﻢ وزن ﺣﻲ/ ﻣﻠﺠﻢ ﺑﺮوﻣﺎت اﻟﺒﻮﺗﺎﺳﻴﻮم 06ﻓﻲ اﻟﻤﺎﻋﺰ اﻟﻤﺠﺮع ﺑـ 
ﺳﺠﻞ  . و ﺗﺪﻧﻲ اﻟﺸﻬﻴﺔ واﻹدﻣﺎع أﻋﺮاض اﻟﺮﻗﺎد وﺷﺢ اﻟﺘﺒﻮل وﺗﻠﻮﻧﻪ ﺑﺎﻟﺪم، اﻹﺳﻬﺎل وﺳﻴﻼن اﻷﻧﻒﻣﻦ ﺑﺮوﻣﺎت اﻟﺒﻮﺗﺎﺳﻴﻮم
   .ج واﻟﻤﺠﻤﻮﻋﺔ ب ﻓﻲ اﻟﻤﺠﻤﻮﻋﺔ   (50.0 >ب )ﻧﻘﺺ اﻟﻮزن 
  
ﻟﻤﺠﻤﻮﻋﺎت ﻓﻰ ﻓﺘﺮة ﻓﻰ آﻞ اﻓﻰ  اﻟﻌﺪد اﻟﻜﻠﻰ ﻟﻜﺮﻳﺎت اﻟﺪم اﻟﺒﻴﻀﺎء واﻟﺤﻤﺮاء ( 50.0>ب) هﻨﺎﻟﻚ ﻧﻘﺼﺎن واﺿﺢآﺎن           
 . آﻞ ﻣﺴﺘﻮﻳﺎت اﻟﺘﺠﺮﻳﻊ ﻓﻰﻟﻬﻴﻤﻮﻗﻠﺒﻴﻦ و ﺣﺠﻢ اﻟﺨﻼﻳﺎ اﻟﻤﺘﺮاص ﻧﺴﺒﺔ اﻓﻲ ( 50.0< ب  ) ﺗﻐﻴﻴﺮﻳﻜﻦ هﻨﺎﻟﻚ ﻣﻦﻟﻢ . اﻟﺘﺠﺮﻳﻊ
ﻓﻲ ﻣﺘﻮﺳﻂ ﺗﺮآﻴﺰ هﻤﺠﻠﻮﺑﻴﻦ اﻟﺨﻠﻴﺔ ﻓﻲ ﻓﺘﺮة اﻟﺘﺠﺮﻳﻊ ﻓﻲ اﻟﻤﺠﻤﻮﻋﺔ ج و د ﻣﻊ زﻳﺎدة ( 10.0>ب) آﺎن هﻨﺎﻟﻚ ﺗﺪﻧﻴًﺎ ﻣﻌﻨﻮﻳًﺎ
ﻓﻲ ﻣﺘﻮﺳﻂ ﻗﻴﻢ ﺣﺠﻢ اﻟﺨﻼﻳﺎ آﺎﻧﺖ هﻨﺎك زﻳﺎدة ﻣﻌﻨﻮﻳﺔ .  ﻓﺘﺮة اﻟﻨﻔﺎهﺔ ﻓﻲ اﻟﻤﺠﻤﻮﻋﺔ ب و ج ﻓﻲ( 10.0>ب)ﻣﻌﻨﻮﻳﺔ 
ﻓﻲ اﻟﻤﺠﻤﻮﻋﺘﻴﻦ ب و ج ﻓﻲ ﻓﺘﺮة ( 10.0>ب)ﻓﻲ ﻓﺘﺮة اﻟﺘﺠﺮﻳﻊ ﻓﻲ اﻟﻤﺠﻤﻮﻋﺘﻴﻦ ج و د وآﺬﻟﻚ زﻳﺎدة ﻣﻌﻨﻮﻳﺔ ( 10.0>ب)
اﻻﻟﺒﻴﻮﻣﻴﻦ ،اﻟﺒﺮوﺗﻴﻦ اﻟﻜﻠﻰ. ﻟﻤﺠﻤﻮﻋﻪ دﻓﻰ ا( 50.0<ب )ًﺎ واﺿﺤًﺎاﻟﻴﻮرﻳﺎ واﻟﻜﺮﻳﺎﺗﻴﻨﻴﻦ اﻇﻬﺮا ﻧﻘﺼﺎﻧﺗﺮآﻴﺰي . اﻟﻨﻘﺎهﺔ
ﻓﻰ آﻞ ( 50.0<ب)ًﺎ  واﺿﺤًﺎ ﻓﻴﻪ ﻧﻘﺼﺎﻧﻲﺤﻤﺾ اﻟﺒﻮﻟاﻟ. ﻓﻰ آﻞ اﻟﻤﺠﻤﻮﻋﺎت( 50.0<ب)واﻟﻘﻠﻮﺑﻴﻮﻟﻴﻦ اﻇﻬﺮا زﻳﺎدﻩ واﺿﺤﻪ
( 50.0<ب)اﺿﺤﻪ اﻟﻔﺴﻔﻮر اﻇﻬﺮ زﻳﺎدﻩ و. ﻓﻰ اﻟﻤﺠﻤﻮﻋﻪ د( 50.0<ب)اﻇﻬﺮت ﻧﺴﺒﺔ اﻟﺼﻮدﻳﻢ زﻳﺎدﻩ واﺿﺤﻪ. اﻟﻤﺠﻤﻮﻋﺎت
  . ﻓﻰ آﻞ اﻟﻤﺠﻤﻮﻋﺎت
  
 ﺣﺘﻘﺎناﻹ.  إﺣﺘﻘﺎن اﻟﻤﻌﻲ واﻣﺘﻼء وﺗﻀﺨﻢ اﻟﺼﻔﺮاءأﻇﻬﺮتآﺠﻢ وزن ﺣﻲ / ﻣﻠﺠﻢ 09 اﻟﻤﺠﻤﻮﻋﺔ اﻟﺘﻲ أﺟﺮﻋﺖ 
آﺠﻢ / ﻣﻠﺠﻢ ﺑﺮوﻣﺎت اﻟﺒﻮﺗﺎﺳﻴﻮم 06  و09 ﺑـ  اﻟﻤﺠﺮﻋﺘﻴﻦ د و ج ﻲ اﻟﻜﺒﺪ واﻟﻜﻠﻲ ﻟﻮﺣﻈﺎ ﻓﻲ اﻟﻤﺠﻤﻮﻋﺘﻴﻦ ﻓﺪهﻨﻲاﻟﺘﻨﻜﺲ اﻟو
ﺒﺪ، إﺣﺘﻘﺎن وﺗﻮرم ﺧﻼﻳﺎ اﻻﻧﻴﺒﻴﺒﺎت ، وﺗﺴﻠﺦ اﻟﺨﻼﻳﺎ  وﻣﻮت اﻟﺨﻼﻳﺎ ﻓﻲ اﻟﻜﺸﺮاﺋﺢ اﻟﻤﺮﺿﻴﺔ ﺗﺤﻠﻞأﻇﻬﺮت اﻟ .وزن ﺣﻲ 
آﺠﻢ / ﻣﻠﺠﻢ09ﺠﺪﻳﺎن اﻟﻤﺠﺮﻋﺔ ﺑـاﻹﺣﺘﻘﺎن اﻟﻈﺎهﺮ وﺗﻐﻠﻆ  ﺣﻮاﺟﺰ اﻷآﻴﺎس اﻟﻬﻮاﺋﻴﺔ ﻓﻲ اﻟ اﻟﻈﻬﺎرﻳﺔ ﻟﻼﻧﻴﺒﻴﺒﺎت اﻟﻜﻠﻮﻳﺔ ﺑﺠﺎﻧﺐ
آﺎﻧﺖ ﺗﻀﺨﻢ  آﺠﻢ وزن ﺣﻲ/ ﻣﻠﺠﻢ ﺑﺮوﻣﺎت اﻟﺒﻮﺗﺎﺳﻴﻮم 06اﻵﻓﺎت ﻓﻲ اﻟﻤﺎﻋﺰ اﻟﻤﺠﺮع ﺑـ  .وزن ﺣﻲ ﻣﻦ ﺑﺮوﻣﺎت اﻟﺒﻮﺗﺎﺳﻴﻮم
وارﺗﺨﺎء ﻓﻲ اﻻﻧﻴﺒﻴﺒﺎت اﻟﻜﻠﻮﻳﺔ ﻣﻊ إﻓﺮاط  ﻣﻮﺿﻌﻲ ﻟﻠﺨﻼﻳﺎ اﻟﻠﻤﻔﻴﺔ ﻓﻲ اﻟﻜﺒﺪ، زﻳﺎدة ﺧﻠﻮﻳﺔ ﻓﻲ ﻋﻨﺎﻗﻴﺪ اﻟﻤﻜﺒﺒﺎت وﺗﺨﻠﻞ ﺧﻠﻮي
 ﻣﻠﺠﻢ 03ﻓﻲ ﻣﺠﻤﻮﻋﺔ اﻟﻤﺎﻋﺰ اﻟﻤﺠﺮع ﺑـ . اﻟﺘﺮﺳﺐ اﻟﺪﻣﻮي اﻟﺤﺪﻳﺪي ﻓﻲ اﻟﻠﺐ اﻷﺣﻤﺮ ﻓﻲ اﻟﻄﺤﺎل ﻣﻊ ﺗﺮﺑﻴﻘﺎت واﺿﺤﺔ ﻓﻴﻪ
وﻓﻲ   ﺧﻼﻳﺎ اﻟﻜﺒﺪ وﺗﺮاص آﺘﻠﻲ ﻟﻠﺨﻼﻳﺎ ﻣﻨﻬﺎ اﻟﻠﻤﻔﻴﺔ ﺑﺼﻔﺔ رﺋﻴﺴﻴﺔ،  آﺎن هﻨﺎﻟﻚ  ﺗﺤﻠًﻼ ﻓﻲﻲآﺠﻢ وزن ﺣ/ﺑﺮوﻣﺎت اﻟﺒﻮﺗﺎﺳﻴﻮم 
أﻇﻬﺮت اﻹﻣﻌﺎء ﺧﻤﻼت ﻣﺴﺘﺪﻗﺔ اﻟﻄﺮف ،  .أﻇﻬﺮ اﻟﻄﺤﺎل ﻟﺒًﺎ أﺣﻤﺮا ﻇﺎهﺮًا ﺑﻮﺳﻂ إﻧﺘﺎﺷﻲ. اﻟﻜﻠﻲ ارﺗﺨﺎء اﻻﻧﻴﺒﻴﺒﺎت اﻟﻜﻠﻮﻳﺔ
  .ﻏﺪد  ﻣﺘﻄﺎوﻟﺔ ووزﻣﺔ ﻓﻴﻤﺎ ﺗﺤﺖ اﻟﻄﺒﻘﺔ اﻟﻤﺨﺎﻃﻴﺔ
ﻃﺒﻘﺖ ﻓﻲ  آﻠﻮﻳًﺎ ﻟﺠﺪﻳﺎن اﻟﻤﺎﻋﺰ اﻟﻨﻮﺑﻲ ﻓﻲ ﻣﺴﺘﻮي اﻟﺠﺮﻋﺎت اﻟﺘﻲ -آﻴﻤﻴﺎﺋﻴًﺎ آﺒﺪﻳًﺎ ﻣﺴﻤًﺎﺒﻮﺗﺎﺳﻴﻮم ﺑﺮوﻣﺎت اﻟاﻋﺘﺒﺮ 
اﻟﺘﺠﺮﺑﺔ
Nimtalla, Hanan M., MVSc. Thesis, 2008 
 1 
  
INTRODUCTION 
            The environmental chemical toxins are many, and can exert their effects 
indiscriminately on both man and animals. In the Sudan, the misuse of or 
pollution with different insecticides in veterinary drug therapies and prophylaxes 
have direct effect on animals (Brown, 1979a and WHO, 1989). Indirect effects 
on animals are exerted through agricultural products like fodder, agricultural by-
products like stovers or agro-industrial by-products like brans and cakes. 
Chemical toxins effects on animals are exerted also indirectly through polymer 
water flocculants used recently like the organic polyelectrolyte polymer (poly-
DADMAC) polyallyl-dimethyl-ammonium chloride (Medani, 2004), petroleum 
refining gas emissions (sulphide gases) and its polluted water effluents with 
hydrocarbons and heavy metals (El Amin, 2004 ). Currently, the bread improver 
potassium bromate has become a worry as a notified chemical toxin, though was 
historically used as flour improver.  
            It is not out of expectations that yesterdays widely used feed additives, 
improvers or other multi purpose used chemicals will be proved toxic or 
carcinogenic through continuous and genius experimentation. In the Sudan 
Potassium Bromate was first introduced before 50 years as feed additive to 
bread (use rate 70 ppm) to be an improver, providing strength and stability 
(B.U., 2003). Internationally, potassium bromate was prohibited in 1998 when 
the above toxicity reports were evident. Hence prohibition was adopted in the 
country. Illegal usage of potassium bromate was still reported in some bakeries.   
           Basic chemical toxic effects on animals, namely domestic small 
ruminants kept in the backyard like goats, which can feed on household 
remnants including disposed potassium bromate improved bread, were not 
investigated. This study was designed to test the basic chemical toxicity of 
potassium bromate to Nubian goat kids. 
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CHAPTER ONE 
LITERATURE REVIEW 
 
         In this Chapter, toxicity of elemental reference halogens and their 
compounds was covered. The halogenic compound potassium bromate 
properties, toxicokinetics and toxicity profiles were reviewed.    
  
1.1 Halogens          
The halogens or halogen elements are a series of nonmetal elements from 
Group 17 (formerly group 7 or 7a)  of the Periodic Table, comprising fluorine F, 
chlorine Cl, bromine Br, iodine I and astatine At. All halogens have 7 electrons 
in their outer shells, yielding an oxidation number of -1 (Delpierre and Sewell, 
1992). 
  Owing to their high reactivity, the halogens are found in the environment 
only in compounds or as ions. Halide ions and oxoanions such as IO3− can be 
found in many minerals and in seawater. Halogenated organic compounds can 
also be found as natural products in living organisms. In their elemental forms, 
the halogens exist as diatomic molecules, but these only have a fleeting 
existence in nature and are much more common in the laboratory and in 
industry. At room temperature and pressure, fluorine and chlorine are gases, 
bromine is a liquid and iodine and astatine are solids (Greenwood and 
Earnshaw, 1997 and Thomas, 2000). 
Halogens are highly reactive, and as such can be harmful or lethal to 
biological organisms in sufficient quantities. Fluorine is the most reactive 
element in existence, attacking such inert materials as glass and forming 
compounds with the heavier noble gases. It is a corrosive and highly toxic gas. 
The reactivity of fluorine is such that if used or stored in laboratory glassware 
can react with glass in the presence of small amounts of water to form SiF4. 
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Chlorine and iodine are both used as disinfectants for drinking water, swimming 
pools, fresh wounds, dishes, and surfaces. They kill bacteria and other 
potentially harmful microorganisms i.e. used for sterilization. Their reactivity is 
also put to use in bleaching. Chlorine is the active ingredient of most fabric 
bleaches and is used in the production of most paper products (WFE, 2007 and 
W.E., 2007). 
The halogens react with each other to form interhalogen compounds. 
Diatomic interhalogen compounds (e.g. BrF, ICl, ClF). Many synthetic organic 
compounds such as plastic polymers and a few natural ones, contain halogen 
atoms; these are known as halogenated compounds or organic halides 
(Greenwood and Earnshaw, 1997 and Thomas, 2000). 
The halogens all form binary compounds with hydrogen, the hydrogen 
halides HF, HCl, HBr and HI, a series of particularly strong acids. When in 
aqueous solution, the hydrogen halides are known as hydrohalic acids. HAt or 
hydrastatic acid should also qualify, but it is not typically included in 
discussions of hydrohalic acids due to astatine's extreme instability towards 
alpha decay (WFE, 2007 and W.E., 2007). 
 
1.1.1 Fluorine  
           Fluorine is present in all animal tissues, highest concentration being 
found in the bones and teeth (Velu, 1932). Toxic quantities of fluorides occur 
naturally, certain rock phosphate and the superphosphates are produced from 
them. In certain areas drinking water from deep wells may contain high level of 
fluorides. Volcanic ash may be high in fluorides. Wastes from industrial 
processes, fertilizers and mineral supplements are the most common sources of 
chronic fluorosis (Merck, 2004).  
There is a general correlation between the solubility of a fluoride and its 
toxicity. Out of fluorides, sodium fluoride is the most toxic and the calcium 
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fluoride is the least toxic. Acute poisoning from inhalation of fluorine-
containing gases or from ingestion of rodenticides or acaricides containing 
fluoride is rare. The fatal dose of sodium fluoride is 5-10 mg/kg and toxic 
effects occur below 1 mg/kg. Fluoride, 75-90% absorbed over 90 minutes 
lowers serum calcium and magnesium (Merck, 2004). Symptoms are 
gastroenteritis, vomiting, abdominal pain, diarrhea, muscular weakness and in 
severe cases collapse and death. Cardiac ventricular tachycardia and nervous 
sings may be noted after a few hours, collapse and death (Clarke and Clarke, 
1967).  Padberg (1972) noted poisoning in cattle due to potassium ammonium 
bifluoride. Symptoms are diarrhea and fall in milk, Gastroenteritis with 
complete anorexia, vomiting and diarrhea in pigs (Radostits et al., 1994). In 
sheep and goat poisoning with fluorosilicate, signs of salivation, inappetance, 
dullness, dyspnoea, recumbency, clonic convulsions and increase in heart rate 
are observed (Egyed and Rosner, 1968).     
                Chronic fluorosis causes skeletal sings, changes in the development of 
teeth leading to chalkiness, staining and rapid irregular wear (Merck, 2004). 
The chief clinical sign of fluorosis in severely effected cattle is lameness 
(Towers, 1954) which is usually associated with marked skeletal abnormalities, 
enlargement of sternum and lower jaw, and in severe cases, an increase in the 
diameter of the metacarpals and metatarsals. Dental lesions are commonly the 
first signs of fluorosis (Bauer, 1945). In cattle, Blakemore et al. (1948) found 
dental changes and the teeth lose their luster and become pitted. In sheep, 
Boddie (1945) described tooth changes similar to those seen in cattle. Gottlieb 
and Grant (1932) reported the same finding in dogs poisoned with sodium 
fluoride. Chronic fluoride intoxication in horses including dental changes, 
crooked legs, hyperostosis and enostosis, hoof deformities and microscopic 
evidence of reduced bone resorption (Lennart et al., 2006). 
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1.1.2 Chlorine  
Chlorine is a greenish-yellow gas that is slightly soluble in water 
(ACGIH, 1986). The chemical formula for chlorine is Cl2, and its molecular 
weight is 70.90 g/mol (Calabrese and Kenyon, 1991). Chlorine has a 
suffocating odor; the odor threshold is 0.31 ppm (Amoore and Hautala, 1983). 
Chlorine is used for water disinfection and for treatment of sewage effluent. It is 
also used to disinfect equipment, utensils in beverage, food processing plants, 
and as an intermediate in the manufacture of a number of organic products such 
as antifreeze, rubber, cleaning agents and pharmaceuticals (Calabrese and 
Kenyon, 1991 and EPA, 1993). 
 Exposure to chlorine can occur through inhalation, ingestion and eye or 
skin contact (Genium, 1992).  Chlorine is a severe irritant of the eyes, mucous 
membranes, skin, and lungs in experimental animals (NIOSH, 1992 and 
ACGIH, 1991). The 1 hour LC50 is 239 ppm in rats and 137 ppm in mice (Sax 
and Lewis, 1989). Animals surviving sublethal inhalation exposures for 15 to 
193 days showed marked emphysema, which was associated with bronchiolitis 
and pneumonia (Clayton and Clayton, 1982). Chlorine injected into the 
anterior chamber of the rabbits' eye resulted in severe damage with 
inflammation, opacification of the cornea, atrophy of the iris, and injury to the 
lens (Grant, 1986).  
Animal studies have reported decreased body weight gain, eye and nose 
irritation, and effects on the respiratory tract, liver and kidney from chronic 
inhalation exposure to chlorine. Other studies have indicated that exposure to 
chlorine, via inhalation, may alter disease resistance in animals, with higher 
incidences of emphysema, pneumonia, and tuberculosis reported. Chlorine has 
not been found to be carcinogenic in animals; no tumors were noted in a study 
where rats were exposed to 100 ppm chlorine in their drinking water over their 
lifespan, for 7 generations (Calabrese and Kenyon, 1991). Another study 
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evaluated the potential carcinogenicity of chlorinated drinking water in rats and 
mice and found no statistically significant increase in tumors that could be 
related to the chlorinated water (EPA, 1993). 
 
1.1.3 Iodine  
 Chemically, iodine (atomic number 53) is the least reactive of the 
halogens and the most electropositive halogen after astatine. Iodine is primarily 
used in medicine, photography and dyes. It is required in trace amounts by most 
living organisms. Iodine naturally occurs in the environment chiefly as dissolved 
iodide in seawater, although it is also found in some minerals and soils. The 
element may be prepared in an ultra pure form through the reaction of potassium 
iodide with cupric sulfate. Iodine is used in pharmaceuticals, antiseptics, 
medicine, food supplements, dyes, catalysts, halogen lights, photography and 
water purifying (WFE, 2007). 
In areas where there is little iodine in the diet, typically remote inland 
areas and semi-arid equatorial climates where no marine foods are eaten, iodine 
deficiency gives rise to thyroid hyperplasia, reproductive failure and hair and 
wool loss (Mills, 1983).  Iodine deficiency during pregnancy has particularly 
adverse effects causing retardation of foetus development, its death, dead or 
weak neonates with hyperplastic thyroid goitre. These findings were reported in 
cattle (Kursa et al., 1996 and Herzig and Suchy, 1996), sheep (*Radostits et 
al., 1994), and goats (Radostits et al., 1994 and Bires et al., 1996).  
Iodine is the essential element used by the thyroid for the biosynthesis of 
thyroid hormones (Thilly et al., 1992). Through these hormones, iodine is 
involved in controlling metabolism, cell growth and maturation, and the 
development and growth of tissues (Hetzel, 1989). Iodine has direct effects on 
thymus development, the development and function of various immune cells and 
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antigenicity of the thyroid (Ruwhof and Drexhage, 2001). Occurrence of 
functional thyroid disorders has been increasing in animals, especially in new-
born calves and lambs (Korber et al., 1985; Kursa et al., 1996; Bires et al., 
1996 and Sargison et al., 1998). Iodine toxicity is rare in animals and humans, 
but nuclear explosions that give off radioactive iodine and excessive stable 
iodine ingestion in parts of the world where seaweed is consumed represent 
specialized iodine toxicity concerns. Chronic over consumption of iodine 
reduces organic binding of iodine to the thyroid gland, which results in 
hypothyroidism and goiter. Bromine can replace Iodine on position 5 of both T3 
and T4 with no loss of thyroid hormone activity (Baker, 2004). 
All animal species appear to have a wide margin of safety for excess 
iodine consumption. Dietary iodine levels of 500 to 1000 times the minimal 
dietary required level are generally well tolerated in rats, pigs, chicks, and 
ruminants. Among the species studied, horses seem to be the most susceptible to 
iodine toxicity. Chronic consumption of diets with high levels of iodine, for 
example kelp consumption by horses, markedly reduces organic binding of 
iodine by the thyroid gland, resulting in goiter in the offspring of mares (NRC, 
1980).  
 Studies by Arrington et al. (1965; 1967) in rabbits and hamsters, 
Ammerman et al. (1964), in rats, Wilgus et al. (1953) in pigs and Newton and 
Clawson (1974) in chicks suggest that these species can tolerate dietary iodine 
levels up to 500 mg/kg, but rabbits experience serious mortality in offspring 
when 250 mg/kg is fed to the dam in late gestation. In hundred kg calves, 
however, iodine toxicity signs coughing and nasal discharge occurred when 
supplemented iodine from calcium iodate reached a dietary level of 50 mg/kg 
(Newton et al., 1974). Perdomo et al. (1966) fed laying hens iodine levels 
ranging from 312 to 5000 mg/kg diet and found that egg laying ceased within a 
week in hens fed the highest iodine level at 312 mg iodine/kg and egg 
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production was reduced. Within 7 days of iodine recovery, egg production 
returned to normal, even in hens that had been fed 5000 mg iodine/kg. 
 Radiation exposure above a threshold level can cause either death or 
modification of living cells. Radiation-induced cancer can occur decades after 
exposure (UNSCEAR, 2000). Because oral Br administration as NaBr was so 
effective in reversing iodine toxicity in growing chickens and because efficacy 
was likely due to blockage of iodine uptake by the thyroid, one could speculate 
that bromide administration might be effective in blocking thyroidal uptake of 
radioactive iodine in humans (Baker, 2004). 
 
1.1.4 Astatine 
Astatine (At) is a semi metallic radioactive chemical element which is the 
heaviest halogen. Small amount of astatine exist in equilibrium with uranium 
and thorium in the earth crust, but the total amount of astatine is probably less 
than 1 oz. Chemical proprieties are believed to be similar to those of iodine. 
Astatine-211 sometimes used as radioactive tracer like iodine and similarly it 
collects in the thyroid gland (WFE, 2007). 
The toxicity of the alpha particle emitting halogen astatine-211 was 
examined in male and female mice. Pathological changes were seen in mice 
killed at 14 days and/or at 56 days following a single injection of 61 kBq 
astatine-211 per g body weight. The tissues affected, in order of severity, were 
spleen, lymph nodes, bone marrow, gonads, thyroid, salivary glands and 
stomach (Cobb et al., 1988). 
 
1.1.5  Bromine 
Bromine is the only non-metallic element that is liquid at room temperature 
and standard pressure. It is a liquid that easily evaporates and smells. It has 
periodic number of 4, atomic weight of 79.904 and an atomic number 35 like 
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chlorine. It is a heavy, volatile, mobile, dangerous and reddish-brown liquid. 
After fluorine, bromine is the most reactive element. In nature bromine can only 
be found in compounds that are called bromides.  Bromine occurs in seawater as 
a sodium salt but in much smaller quantities than chloride. It is recovered 
commercially through the treatment of seawater with chlorine gas. In this 
treatment, bromide (2Br -) is oxidized to bromine (Br2) by chlorine gas which is 
reduced (2Cl-) ultimately (W.E., 2007). Small amounts of bromine can also be 
made through the reaction of solid sodium bromide, with concentrated sulphuric 
acid: 
NaBr + H2SO4                     HBr + NaHSO4 
2HBr + H2SO4                      Br2  + SO4 +2HO2 
 
Sodium bromate, and likely Potassium bromate, are white crystalline 
substances (Budavari et al., 1989). The alkaline, metallic element potassium 
(K+) belongs to group IA of the periodic Table and has an atomic weight of 39.1. 
It is a soft, silvery metal, which is rapidly oxidized. Potassium is widely 
distributed in nature in silicate rocks and also occurs in salts beds and seawater 
(EGVM, 2002). Potassium is not found as a pure metal in nature, being easily 
ionised to the cation K+ through the loss of an outer electron. It always combines 
with other substances, the most common form being the chloride salt (Macrae 
et al., 1993). 
 
1.2 Potassium bromate 
          Synonyms are bromic acid and potassium salt, molecular formula KBrO3 
and molecular weight 167.01. Appearance is odorless, tasteless white powder or 
crystals. It melts at 350o C and decomposes at 370o C. Solubility in water is 133 
g/L at 40 o C. Slightly soluble in alcohol and insoluble in ether (Sax and Lewis, 
1989 and Weast, 1985). It is classified in the hazard class 5.1 at a hazard rating 
of 2.  
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             Potassium bromate is stable under the ordinary conditions of use and 
storage. Contact with oxidizable substances may cause extremely violent 
combustion. Incompatibilities are mainly acids, reducing agents, organic 
material, powder metals and metal sulfides. Conditions to avoid are heat, flame, 
moisture, dusting and incompatibles (Appendix 1). 
 
1.2.1 Uses 
Potassium bromate it is not a naturally occurring and it is produced by 
passing bromine into a solution of potassium hydroxide (IARC, 1986). 
Potassium bromate is an oxidizing agent used mainly as a food additive and it 
has no medicinal uses. It was until recently used in flour milling, beer malting 
and cheese making (IARC, 1986; Chipman et al., 1998 and EGVM, 2002). It 
used also in the production of fish paste and fermented beverages (IARC, 1986). 
It also used as a permanent hair wave neutralizing agent ( DeVriese et al., 1997 
and EPA, 2001) .The wavy hair is produced by a formulation kit of ammonium 
thioglycolate that reduces the keratin disulphydral bond to sulfhydral. Post 
makeup utilizes a neutralizing solution which contain potassium bromate or 
iodate that converts back the disulphide bond to stabilize the new form of hair. It 
is also used as a primary standard and brominating agent in analytical chemistry 
and in the production of explosives (DeVries et al., 1997).   
Bromate may be found in some drinking water samples as by-product of 
ozone disinfection (Ueno et al., 2000 and K.C., 2006). It is currently regulated 
in treated drinking water at maximum contaminant level of 10µg/l in USA and 
Europe (EPA, 2001). Potassium bromate under the right conditions will be 
completely used up in the baking bread. However, if too much is used, or the 
bread is not cooked long enough or at high enough temperature, then residual 
amount will remain (WFE, 2006). This residual amount of potassium bromate is 
undesirable. Bromate is an oxidizing improver which acts slowly and throughout 
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the dough fermentation, and has two primary effects. Firstly, it enables loafs 
with high volume qualities to be produced from the low protein wheats. 
Secondly, it helps to produce bread with fine crumb structure. Potassium 
bromate is a highly reactive substance which rapidly breaks down to the inactive 
bromide during dough fermentation and baking and it was always considered 
that breakdown was complete (MAFF, 1993).  
         Normally, potassium bromate is used at levels less than 70 parts per 
million parts of flour or less than 45 parts per million of finished dough. Normal 
usage levels are 10 to 30 parts per million and when used at these low levels a 
majority of the potassium bromate reacts, and if there is any remaining, it will be 
evaporated during the baking process, hence, residual potassium bromate levels 
are measured in part per billion. The Food and Drug Administration (FDA) feels 
that 20 parts per billion or less of potassium bromate is safe (K.C., 2006).            
Potassium bromate in bread and baked food as low 5ppb (ng/g) can be detected 
using liquid chromatography (Himata et al., 2000). Dennis et al. (1994) 
detected potassium bromate to limit of 12 µg/kg bread using gas 
chromatography.  
 
1.2.2 Toxicokinetics  
1.2.2.1 Absorption  
The vast majority of intestinal absorption of potassium occurs in the small 
intestine, with the contribution of the colon being minor (Agarwal et al., 1994). 
Absorption of dietary potassium is very efficient and more than 90% of the 
ingested potassium is being absorbed (NAS, 1980). Phillips and Giller (1973) 
found absorption by the small bowel to be about 85% of the dietary potassium 
intake. 
Bromate appears to be rapidly absorbed from the gastrointestinal tract, at 
least in part unchanged. Fujii et al. (1984) administered a single dose of 
potassium bromate (50 mg BrO3-/kg intra-gastric) to male Wistar rat and the 
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bromate was rapidly absorbed from the digestive tract. Parker and Barr (1951) 
reported that bromate is absorbed from the stomach unchanged, following 
incubation of normal human gastric juice with potassium bromate at 38оC for 3 
days. 
 
1.2.2.2 Distribution  
Bromate is distributed throughout the body, appearing in plasma and urine 
unchanged and in other tissues as bromide. Fujii et al. (1984) administered 
orally 100 mg/kg potassium bromate to rats to result in peak urine concentration 
one hour after dosing and peak plasma concentration 15 minutes after dosing. In 
addition, bromide was significantly increased in kidney, pancreas, stomach, 
small intestine, red blood cells and plasma 24 hour after administration. 
 
1.2.2.3 Metabolism  
About 90 -95% of ingested potassium is being utilized in normal 
metabolic pathways (Navarro and Vaquero, 1999). Potassium is transported 
mainly in ionic form in the extracellular liquid (Fordtran and Lockelear, 
1966). Bromate is reduced to bromide in the body tissues. Fujii et al. (1984) 
administered intra-gastric single dose of 50 mg Bro3-/kg to rats and after 24 
hours measured bromate level in tissues, bromate was not detected in any of 
eight tissues analyzed, but significantly increased bromide levels were in 
plasma, red blood cells, pancreas, kidney, stomach, and small intestine at 187.1, 
289.0, 32.1, 87.4, 113.5 and 62.5 ug/g respectively. Both bromate and bromide 
were significantly increased in urine reaching 1729.9 and 1314.1 ug/ml, 
respectively. However, Kutom et al. (1990) reported that bromate is very stable 
in the body and only small amount of it is reduced to bromide. Bromate may be 
converted to hydrobromic acid in the stomach. 
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Tanaka et al. (1984) reported glutathione (GSH) is probably involved in 
degrading bromate to bromide. I in vitro studies liver and kidney tissues 
degraded bromate to bromide. 
 
1.2.2.4  Excretion  
The major excretory route of potassium is via the kidney. Experiments 
with dogs had studied the basic mechanisms of renal excretion of potassium. 
More potassium is found in urine than filtered at the glomeruli (Mudge et al., 
1948 and Berliner and Kennedy, 1948). This indicates that potassium must be 
secreted by the renal tubules. Secretion is accomplished by an ion exchange 
mechanism in which potassium of the tubular cells is exchange for the sodium 
of the glomerular filtrate (Berliner et al., 1950). The mechanism of renal 
excretion of potassium in dogs was found to be similar to man (Berliner et al., 
1950). The digestive juices in human contain large a mounts of potassium but 
most is reabsorbed and therefore loss in the faeces is small (Agarwal et al., 
1994). 
Fujii et al. (1984) reported bromate is excreted mainly in the urine, partly 
as bromate and partly as bromide some bromate may also be eliminated in feces. 
Bromate was detected in the urine of rats following oral doses as low as 5mg 
BrO3-/kg. About 30% of an oral dose of 50 mg Bro3- to rats was recovered in 
urine after 24 hours (Fujii et al., 1984).  Only small bioaccumulated or retained 
amounts of bromine not subjected to excretion were detected in the adipose 
tissues of mice treated with potassium bromate in a lifetime study, but not 
detected in rats (Kurokawa et al., 1990).  
 
1.2.3  Mode of action  
         Two mechanisms of potassium bromate mediate DNA damage have been 
proposed direct interaction with DNA following GSH activation and indirect 
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damage via lipid peroxidation (LPO) (Ballmaier and Epe, 1995; Chipman et 
al., 1998). 
         Oxidative stress may play a role in the formation of kidney tumors 
treatment with potassium bromate causes an increase of 8-oxodeoxyguanosine 
(8-OH-dG) in the kidney both total DNA and mitochondrial DNA but not in the 
other organs (Kasai et al., 1987; Kurokawa et al., 1990; Sai et al., 1991; 
1992a; 1992b; 1992c; Cho et al., 1993; Sai et al., 1994; Ballmaier and Epe, 
1995; and Chipman et al., 1998). 
Kasai et al. (1987) studied in vivo formation of 8-OH-dG in liver and 
kidney DNA in response to the administration of potassium bromate. The 
formation of 8-OH-dG in tissue is indicative of damaged DNA. Levels of 8-OH-
dG in the liver of experimental animals were not significantly increased. In the 
kidney 8-OH-dG in the DNA increased up to 6 residues/105 8-OH-dG 24 hours 
after administration of KBrO3 after 48 hours a significant reduction of 8-OH-dG 
was observed, which the authors stated was indicative of the presence of repair 
enzymes in the rats kidney. 
Similar results were found by Cho et al. (1993) who found that potassium 
bromate induced higher 8-Oh-dG levels in kidney than in liver. The 8-OH-dG 
peaked between 24 and 27 hours after treatment with KBrO3 and by 48 hours 
after treatment 8-OH-dG decreased. 
The enzyme that repairs 8-OH-dG is 8- hydroxydeoxyguanosine 
glycosylase. Lee et al. (1996) found this enzyme is induced in a dose dependent 
in the kidney, but not in the liver. 
Resent study suggest that in the kidney there is not a direct mechanism of 
DNA damage rather at a toxic dose, potassium bromate induces DNA damage 
through LPO (Chipman et al., 1998). However, the overall evidence is 
insufficient to establish LPO and free radical production as the key events 
responsible for the induction of kidney tumors. In addition no data are available 
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to suggest that any simple mechanism including oxidative stress is responsible 
for the production of thyroid and peritoneal tumors. 
Some evidence suggests that cell proliferation plays a role in enhancing 
renal carcinogenesis by potassium bromate. Umermura et al. (1993) said that 
α2u- globulin is present in the hyaline droplets observed in male rats’ renal 
tubules following potassium bromate exposure, but not in female rats. Later 
studies in female rats demonstrated that potassium bromate induces cell 
proliferation in renal tubules independent of α2u- globulin (Umemura et al., 
1995). The demonstration of kidney tumors in female rats and mesotheliomas 
and thyroid tumors in male rats suggested that  α2u- globulin is not the primary 
mechanism of potassium bromate carcinogenicity , although it may contribute to 
the apparent sensitivity of male rats to the kidney effects of potassium bromate.  
 
1.2.4Toxicity 
1.2.4.1 Acute toxicity     
Fuji et al. (1988) exposed male Long-Evans rats to single oral doses of 0, 
1.0, 1.5, 2.0, and 3.0 mmol KBrO3/kg equivalent to 0, 129, 192, 257 and 385 mg 
BrO3-/kg. Six hours after administration of bromate, rats receiving the maximum 
dose 385 mg  BrO3-/kg exhibited diarrhea and signs of sedation. They concluded 
that this was the maximum tolerance dose. 
Kurokawa et al. (1990) administered a single intra-gastric dose of 
potassium bromate to rats, mice and Syrian golden hamsters. Tow-thirds of the 
animals in all species receiving high doses (700-900 mg/kg) died within three 
hours, the remaining animals receiving high dose died within 48 hours. LD50 
values were higher for females than for males in all species and ranged from 280 
mg/kg in male mice to 495 mg/kg in female rats. Final signs of toxicity included 
suppression of locomotion, ataxic gait, polypnoea, hypothermia, diarrhea, 
lacrimation and piloerection. In all species during necropsy, hyperemia of the 
glandular stomach mucosa and lung congestion was observed. Kidney damage 
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was observed in rats as early as one hour after treatment, observed epithelial 
dilation and desquamation of the distal convoluted tubules. Necrosis, 
degenerative and regenerative changes of the proximal tubular epithelium was 
also observed after longer exposure. These histological changes occurred later 
and less severe in mice and hamsters. 
Farombi et al. (2002) administered single intra-gastric doses of KBrO3 to 
rats at level 3oo mg/kg body weight. The result showed significant increase in 
relative kidney weight while the body weight and relative liver weight did not 
affected. 
Kawana et al. (1991) administered 0, 100, 500, 1,000, 2,500 and 5,000 
ppm KBrO3 equivalent to 0, 10.8, 54, 108, 270 and 540 mg BrO3-/kg-day in 
drinking water to male mice for 2 weeks. Body weight was lost in the high dose 
group. Examination of the relative kidney, lung and liver weights at necropsy 
revealed significant increases, but dose related changes were not observed. 
Alkaline phosphtase and γ-glutamyl transpeptidase, levels from the 270 and 540 
mg BrO3-/kg-day dose group were significantly increased, but only increases in 
γ -glutamyl transpeptidase levels appeared to be dose related. 
 In another study Okolie and Ikewuchi (2004) indicate that potassium 
bromate induce oxidative stress on some cataractogenic indices 1n lens, cornea 
and retina of white rabbits recovering 60 mg/kg body weight orally for 28 days. 
They also stated  a significant decreases in the activities of Na , K ATPase, 
catalase, superoxide dismutase and anti-oxidant vitamins A and C.  
 
1.2.4.2  Chronic toxicity  
     The subchronic effects of bromate were evaluated by Kurokawa et al. 
(1990) who administered potassium bromate in water at concentrations 0, 150, 
300, 600, 1,250, 2,500, 5,000 and 10,000 ppm equivalent to 0,16,32,63,140 
270,650 and 1,080 mg BrO3-/kg  to F344 rats for 13 week. All animals exposed 
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to >140 mg died within 7weeks. There was an observed significant inhibition of 
body weight in males at 63 mg or above and significant increase of serum 
parameters glutamate oxaloacetate transaminase, glutamate pyruvate 
transaminase, alanine transaminase, lactate dehydrogenase, alkaline 
phosphatase, blood urea nitrogen, Na+ and cholinesterase in both sexes. Serum 
potassium levels were significantly decreased. Droplets of various sizes and 
regenerative changes in renal tubules were observed. 
Kurata et al. (1992) administered single intra-gastric doses of KBrO3 to 6 
old male rats for 104 weeks at dose levels 0, 50, 300, 600 and 1200 mg/kg body 
weight. All rats treated with 1200 mg/kg and 4 of 5 rats treated with 600 mg/kg 
died within 24 hours of dosing. The remaining animals survived until sacrificed 
four weeks later. Of rats found dead, necrosis of the proximal tubules was 
observed. In surviving rats given 300 mg/kg, basophilic regenerative tubules and 
focal accumulation of eosinophilic droplets in the proximal tubules were 
observed, but not in the untreated animals or animals treated with 50 mg/kg.   
           Nakano et al. (1989) exposed male Wister rats to potassium bromate 
about 30 mg BrO3-/kg-day in drinking water for up to 15 months. Body weight 
gain was markedly inhibited. Histological examination of kidneys at 7-11 weeks 
revealed karyopyknotic foci (a necrotic change characterized by shrinking of the 
nucleus and condensation of the chromatin) in tubules of the inner medulla, 
increased Blood urea nitrogen after 15 months with marked structural 
abnormalities of the cortical tubules. 
Kurokawa et al. (1983) investigated the carcinogenicity of potassium 
bromate in the drinking water of rats at concentrations of 0, 250 and 500 ppm 
for 110 weeks. Growth of males in the high dose group was severely inhibited; 
the concentration was reduced to 400 ppm at week 60. Body weight was 
significantly reduced in high dose males, survival was reduced in high dose 
males by about week 60 and in low dose males by about week 100. The first 
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tumor was observed at 14 weeks in males and at 58 weeks in females. 
Incidences of several tumor were elevated, including thyroid (male and female), 
adrenal gland (male), large intestine (male and female), liver (male) and spleen 
(male), all this not statisticlly significant in treated rats. In the male rats the 
incidence of renal cell tumor (both adenocarcinomas and adenomas )  and 
peritoneal mesotheliomas were statisticlly significantly increase in both dose. In 
female rats the incidence of renal cell tumor (both adenocarcinomas and 
adenomas)   was statistically significantly increased in both treated dose. A 
variety of non cancer effects were reported, including degenerative changes, 
necrotic, and regenerative change  in renal tubules, formation of hyaline 
droplets, thickening of transitional epitheliem of renal pelvis, papillary 
hyperplasia and papillary growth.  
In chronic study of  bromate carcinogenicity Kurokawa et al. (1986a) 
treated 20-24 male rats with water containing potassium bromate at 
concentration 0, 15, 30, 60, 125, 250 and 500mg/l equivalent to 0, 0.7, 1.3, 2.5, 
5.6, 12.3 and 33 mg  BrO3-/kg-day for 104 weeks. Histological examination of 
tissues only involved counting of neoplastic lesions. The male in the high dose 
had decreased body weight and decreased survival, beginning approximately 
week 70. Statistically, significantly increased incidence of tumors and 
preneoplastic changes, dysplastic foci at 1.3 mg BrO3-/kg-day dose and above, 
kidney tumors at 5.6 mg Bro3-/kg-day dose and above and thyroid tumors and 
mesotheiliomas in the high dose only. 
Kurokawa et al. (1986b) studied the carcinogenic potential of potassium 
bromate in male and female F344 rats and female B6C3F1 mice. Potassium 
administrated in the drinking water. The bromate average doses for mice were 0, 
43.5 and 91.6 mg BrO3-/kg-day. The average bromate doses for rats were 0, 9.6, 
and 21.3 mg BrO3-/kg-day in males and 0, 9.6, and 19.6 mg Bro3-/kg-day in 
females. Male rats in the high dose marked decrease in body weight and 
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decreased in survival, beginning approximately at week 70. Several 
nonneoplastic effects were seen, significant decreased in serum chemistry, 
include glutamate pyruvate transaminase, albumin to globulin ratio, potassium 
and cholinesterase were observed in female rats in the high dose also slightly 
increase Blood urea nitrogen in both male and female rats. Degenerative and 
necrotic kidney lesions were observed in treated rats. Statistically significantly 
tumors observed in rats included renal cell adenomas and carcinomas and 
peritoneal mesotheliomas in male only.  The high incidence of tumors was 
observed in the thyroid this incidence was not statistically significantly. In the 
male rats the earliest renal tumors was observed at 14 weeks and the earliest 
mesotheliomas was observed at 72 weeks.In female rats the earliest renal tumors 
was observed at 85 weeks. In female mice no significant tumors incidence. 
Potassium bromate is carcinogenic in rats of both sexes, but not in mice. 
Kurokawa et al. (1987) exposed male F-344 rats water containing 500 
ppm potassium bromate ( 29.6-35.5 mg BrO3-/kg) for 13, 26, 39, or 52 weeks 
and studied the incidence of renal cell tumors at 104 weeks. The incidence of 
renal dysplastic foci, adenomas, and adenocarcinomas in rats exposed for 13-52 
weeks was equal to or greater than that in rats receiving potassium bromate 
treatment continuously for 104 weeks. The combined incidence of renal 
adenomas and adenocarcinomas was significantly higher in exposed animals. 
The minimum dose necessary for the induction of renal adenomas and 
adeno carcinomas is acumulative of 4 g KBrO3/kg (3.08 g BrO3-/kg) and the 
minimum treatment period for the induction of these tumors is 13 weeks. 
However, the true minimum treatment time well be shorter than 13 weeks in 
experiment involving shorter exposure period ( Kurokawa et al., 1987 ).  
Matsushima et al. (1986) investigated the carcinogenicity of potassium 
bromate administered subcutaneously to male and female newborn F344 rats 
and ICR mice 24 hours old he gives single dose of 9.6, 19, 38, 77 and 154 mg 
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BrO3-/kg . Another group of newborn rats and mice received four weakly 
injections of 9.6, 19, 38, 77 and 154 mg BrO3-/kg until weaning. Control animals 
received injections of olive oil. Rats were sacrificed at 82 weeks; mice were 
sacrificed at 78 weeks. No differences in the incidence of tumors in male or 
female rats or mice were observed. Under the conditions of the study potassium 
bromate had no potential for carcinogenicity in newborn female or male rats or 
mice. 
Kurata et al. (1992) tested the tumors initiation of bromate in a 104 
weeks study in male F344/Ncr rats were given an itragastric dose of 300 mg 
KBrO3/kg (231 mg BrO3-/kg), the maximum tolerated single dose. Rats were 
administered bromate alone, bromate followed by 4,000 ppm sodium barbital in 
the animals diet as a promoter and sodium barbital alone. Sodium barbital was 
added to the diet 2 weeks after the animals were dosed with potassium bromate. 
Rats were examined at 30, 52, and 104 weeks for nephropathy. At 30 weeks 
renal damage dysplastic foci was evident in the rats exposed to potassium 
bromate followed by sodium barbital and in rats exposed to sodium barbital, but 
not on those exposed to the potassium bromate alone. The results indicated that 
a single oral dose of 300 mg KBrO3/kg administered to rats F344 does not 
initiate renal tumors with 104 weeks. 
DeAngelo et al. (1998) administered potassium bromate to male F344 rats 
and male B6C3F1 mice in drinking water at concentration 0, 0.02, 0.1 and 0.4 
g/L and 0, 0.08, 0.4 and 0.8 g/L respectively.  Dose for rats 0, 1.1, 6.1, 12.9 and 
28.7 mg  BrO3-/kg-day for 100 weeks. For rats 6 animals/ group were included 
for interim sacrifices which occurred at 12, 26, 52 and 77 weeks. In males rats 
survival in the 28.7 mg dose was decreased compared with controls beginning at 
approximately week 79 (Wolf, 1998a) this decrease was statistically significant 
by study termination. Also male rats in 28.7 mg dose group had statistically 
significant decrease in final mean body weight compared with controls. In the 
Nimtalla, Hanan M., MVSc. Thesis, 2008 
 21 
  
12.9 mg dose survival was decrease compared with control beginning at 
approximately week 88 (Wolf, 1998a) this decrease also significant by study 
termination. The effects on survival and body weight in rats indicate that the 
maximum tolerated dose was reached in this study. In rats water consumption 
was statistically significant increased in the 12.9 and 28.7 mg/kg-day dose 
group. Rats in the 12.9 mg/kg-day dose group had increases not statistically 
significant in absolute and relative kidney weight and relative spleen weight. 
Rats in the 28.7 mg/kg-day dose group had statistically significant increases in 
relative liver weight, absolute and relative kidney weight, absolute and relative 
thyroid weight and relative spleen weight. Noneaoplastic kidney lesions were 
observed in rats. There was a  significant dose- dependent increase in the 
incidence of urothelial hyperplasia in rats in the 6.1 mg/kg-day and higher dose 
groups also observed foci of mineralization of the renal papilla and eosinophilic 
droplets in the proximal tubule epithelium, although they did not present any 
information on the dose levels for these findings. 
Tumors incidence for the terminal sacrifice in DeAngelo et al. (1998) 
show  statistically significant, dose-dependent increased tumors incidence in the 
kidney adenomas and carcinomas combined and carcinomas alone, the thyroid 
adenomas and carcinomas combined and carcinomas alone and the tunica 
vaginalis testis mesotheliomas. The earliest renal tumors and mesotheliomas 
were observed at 52 weeks, thyroid tumors were first seen at 26 weeks.  
In the male B6C3F1 mice the result of DeAngelo et al. (1998) indicate 
the mice may be sensitive to the effects of bromate exposure than rats. 
Bromate doses for the mice were 0, 6.9, 32.5 and 59.6 mg BrO3-/kg-day. 
For mice 7 animals/group were included for interim sacrifice which occurred at 
14, 31, 53 and 78 weeks. Bromate in drinking water had no effect in survival, 
body weight and organ weight of male mice. Mice in the 59.6 mg/kg-day dose 
group had statistically significant decrease in water consumption compared 
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(17%) with controls. There was no increased incidence of nonneoplastic lesion 
in any tissue examined of treated mice. The only type of tumors found in male 
mice was kidney tumors However, the incidence of adenoma and carcinoma 
combined was not dose dependent.  
 
1.2.4.3   Reproductive toxicity  
Limited data are available on the reproductive and developmental effects 
of bromate. The reproductive and developmental toxicity of bromate was 
investigated by Wolf and Kaiser (1996) they administered sodium bromate to 
Sprague-Dawley rats orally in the drinking water at concentrations of 0.25 ppm, 
80 ppm and 250 ppm over 35-day period. These doses are equivalent to bromate 
ion 2.2, 7.7 and 22 mg BrO3-/kg-day. Two groups of female rats were treated. 
Group A females (10/group) were dosed from study day 1 to 34 to test for 
effects during conception and early gestation. Group B females (13/group) were 
dosed from gestation day 6 to first postnatal day to test for effects during late 
gestation and birth. Male rats(10/group) were cohabited with group B females 
for 5 days before dosing  and were then dosed from study day 6 to day 34/35. 
Females in group B were allowed to litter and the pups were observed through 
postnatal day 5. However there is no indication of the developmental endpoints 
that were evaluated in these pups or if any effects were observed.  
Treated males in the 250 ppm dose group demonstrated a statistically 
significant decrease (18%) in epididymal sperm density. Female's reproductive 
function was not adversely affected. There were no treatment-related gross or 
microscopic changes in the kidney, spleen, liver, testis and epididymis. These 
results indicate that sodium bromate treatment did not produce any adverse 
general toxicity of the dose level tested. A maximum tolerated dose was not 
reached. 
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1.2.4.4  Genotoxicity   
The genotoxicity of potassium bromate has been evaluated in a variety of 
in vitro and in vivo systems with consistently positive results. Potassium 
bromate has tested positive in the Salmonella typhimurium assay in the presence 
of metabolic activation and in vitro test for chromosomal aberrations using 
Chinese hamster fibroblasts (Ishidate et al., 1984). Dose dependent increases in 
the number of aberrant metaphase cells were observed following single oral 
dose of potassium bromate to Long-Evans rats bone marrow cells receiving dose 
3mmol KBrO3/kg (Fujie et al., 1988).   
Potassium bromate caused significant increases in the number of 
micronuclei following either intraperitoneal injections (Hayashi et al., 1988 and 
Awogi et al., 1992) or gavage dose (Hayashi et al., 1989 and Nakajima et al., 
1989) in mice. Also intraperitoneal injections of potassium bromate in f-344 rats 
resulted in significantly increased micronuclei in reticulocytes peaked at 32 
hours and after the administration of 46 mg BrO3-/kg (Sai et al., 1992a).   
Parsons and Chipman (2000) investigated the effect of potassium 
bromate in isolated calf thymus DNA and a rat kidney epithelial cell line 
(NRK52E). Potassium bromate did not increase levels of 8-oxodG in calf 
thymus DNA at concentration up to 1.5 mM. However, there was dose 
dependent increase in 8-OH-dG in the presence of both KBrO3 (0-1.5mM) and 
GSH (0.5mM). When GSH was substituted by N-acteylsteine (0.5mM) a similar 
dose dependent profile was seen but use of other reducing agents including other 
thiols in combination with KBrO3 did not significantly increase the level of 8-
OH-dG. Potassium bromate induces DNA strand breakage in rats kidney 
epithelial cells treated with 1.5mM KBrO3 for 15 minutes. 
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CHAPTER TWO  
MATERIALS AND METHODS 
2.1 Materials and experimental design 
2.1.1 Animals and housing  
            Twelve apparently healthy male Nubian goat kids, 3-5 months old, 
weighing 10-13 Kg were used in this experiment. Animals were purchased from 
Omdurman Animal Market, Animals Resources Services Company, Animal 
Resources Bank, Sudan. Animals were transported to the premises of the 
Veterinary Hospital, Department of Medicine, Pharmacology and Toxicology, 
Faculty of Veterinary Medicine, University of Khartoum, and kept in the animal 
house with adequate ventilation and appropriate feeding, watering and drainage 
facilities. 
Animals were then rested, watered, ear-tagged and prophylacticly dosed 
with antibiotic Oxytetracycline (Oxtra, Vapco, Jordan) and dewormed with 
anthelmintic Ivomec (Ivermectin, Coopers, UK). Animals were kept for one 
week as an adaptation period prior to the start of the experiment, when animals 
were allotted randomly to four groups A,B,C and D each of three heads. Group 
A was designated as the control group. Group A the numbers of animals 1, 4 and 
8, group B the numbers of animals 2, 6 and 14, group C the numbers of animals 
3, 7 and 9 and group D the numbers of animals 5, 12 and 13.    
             
2.1.2 Feeding and experimental dosing 
All experimental groups were basally fed a concentrate allowance 
(250g/head/day) composed of dura 54%, groundnut cake 20%, wheat bran 25% 
and salt (NaCl) 1%. Groundnut hay as roughage was supplied ad lib. Estimated 
daily intake of energy (2.86 % Mcal) and (20.88 % CP) were up to daily 
requirements (Devendra and Burns, 1983). 
Potassium bromate (KBrO3, Hazard Class 5.1, white odorless and 
tasteless crystals, soluble in water at 133 g/l at 40 oC (Appendix 1), donated by 
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the Sudanese Standards and Metrology Organization, was used as the test 
chemical. Oral daily dosages at concentration rates 0, 30, 60 and 90 mg/kg body 
weight were applied to experimental groups A, B, C and D respectively for 6 
weeks dosing period. Recovery period was adopted thereafter for 4 weeks.  
 
2.1.3 Parameters   
Clinical signs and mortalities were observed daily. Rectal temperature 
(using a certified mercury-in-glass clinical thermometer) and respiration rate (at 
resting; visual flank movements per minute) were recorded daily. Body weight 
was recorded fortnightly. Blood and serum samples were collected fortnightly 
for hematological and serum investigations. Post mortem organs samples were 
collected after death or slaughter and fixed in 10% formalin for further 
histopathological investigation. 
 
2.2 Methods 
The blood samples were collected fortnightly at about 8.00 am from the 
jugular vein, using 10 ml sterile plastic disposable syringes. During the 
collection of samples the goats were kept quiet. Half volume of blood was 
transferred to a test tube containing ethylenediamine tetraacetate (EDTA) and 
used for haematological analayses (Kelly, 1984).  Five ml of blood were 
transferred into clean dry vials, allowed to clot overnight and serum was 
separated by centrifugation at 3000 r.p.m for 10 minutes and then stored at – 
20°C until analyzed.  
 
2.2.1 Haematological methods 
2.2.1.1 Red blood cells count (RBCs) 
Red blood cells were counted with an improved Neubauer 
haemocytometer (Hawksely and Sons Ltd., England). Hayem, s solution was 
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used as a diluent (sodium chloride 1gm,  sodium sulphate 0.5gm, mercuric 
chloride 0.5gm and made up to 200ml with distilled water).   
 
2.2.1.2  Packed cell volume (PCV) 
Fresh blood samples were placed in the capillary haematocrit and tube 
centrifuged in a microhaematocrit centrifuge (Hawksley and Sons Ltd., 
England) for 5 minutes and PCV percentage was read off on the 
microhaematocrit reader provided with the centrifuge. 
 
2.2.1.3 Haemoglobin concentration  (Hb)  
Haemoglobin concentration was determined by the cyanmethaemoglobin 
as described by Van Kampen and Zijlstra (1978) by using Drabkin,s solution    
(Potassium cyanide 0.2g, potassium ferricyanide 0.2g and sodium bicarbonate 
1g in a liter distilled water) .Clean dry test tube were prepared for sample and 
standard. To each tube 4 ml of reagent were added then 0.2 ml of blood sample 
Hb potassium bromate standard solution were added to the sample and standard 
test tube, respectively. The tubes were allowed to stand for 15 min, and then the 
optical density (O.D) was read at 540 nm in a colorimeter. Haemoglobin 
concentration was expressed as follows:     
 Hb concentration (g/dl) O.D samples     X 15 
                                        O.D standard 
15g/d the concentration of standard 
 
2.2.1.4 Red blood cell indices 
2.2.1.4.1 Mean corpuscular volume (MCV)    
MCV was calculated from RBC number and PCV values as follow: 
                  MCV (m3) =           PCV x 10 
                                           RBC in million/mm3  
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2.2.1.4.2  Mean corpuscular haemoglobin  concentration  (MCHC)  
MCHC was calculated from PCV and Hb values as follow 
                  MCHC % =       Hb (g/dl) X 100 
                                                   PCV % 
 
2.2.1.5 White blood cell count (WBCs) 
White blood cells were counted with an improved Neubauer 
haemoycytometer (Hawksley and Sons Ltd. , England) Turk’s fluid (1% glacial 
acetic acid , tinged with gentian violet ) was used as adiluent. 
 
2.2.1.6 Differential  leukocyte  count  
The percentage of neutrophils, monocytes, esinophils and basophils were 
determined microscopically from a count of 100 leukocytes in thin, Giemsa 
stained blood smear (Kelly, 1984). Giemsa stain was prepared by transferring 
3.8g of Giemsa powder to a dry bottle, 250 ml of methanol were added to the 
stain and mixed well, and then 250 ml of glycerol were added and mixed well. 
For use, the prepared Giemsa stain was diluted 1:10 with distilled water.   
The blood smear was prepared freshly blood. The blood was spread 
using the spreader slide, then the smear was dried at room temperature and fixed 
by placing in absolute methyl alcohol for 5 minute. The smear was covered by 
stain for 15 minute, then  the smear was rinsed well in distilled water and 
allowed to dry. The blood film was examined using the oil immersion lens (X 
100).   
 
2.2.2 Chemical methods 
2.2.2.1 Serum metabolites  
2.2.2.1.1 Glucose  
Serum glucose values were determine using enzymatic kits (Plasmatec 
Labs.  Products, Germany). 
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Test principle 
Glucose level was measured according to the method described by 
Paterson (1971):  
Glucose + O2 + H2O                       Gluconate H2O 
2H2O2+ phenol + 4 amino-antipyrine              red chinonimine + H2O. 
 
Dilute enzyme reagent (GOD+ POD + 4-amio-antipyrine was mixed 
with buffer (phosphate buffer, pH 7.5+phenol). 
Non-haemolytic serum was mixed with the reagent solution and the 
mixture was incubated at 37°C for 15 minutes.  The absorbance was read at 
wavelength 500 nm, against the reagent blank calculated as follows:  
U/L=             ∆ A sample         X   standard concentration  
                     ∆ A standard  
(where A = absorbance). 
 
2.2.2.1.2 Total protein  
Total serum protein concentration was measured by the biuret method  
(Weichselbaum, 1946) using commercial kit (Arcomex, Arab Company for 
Medical Diagnostics , Amman, Jordan.) 
Test principle 
The principle is based on the reaction of cupric ions in an alkaline 
solution, with peptide bonds resulting in the formation of a coloured complex.  
The biuret reagent contains sodium hydroxide (0.I-N) , Soduim potassium 
tartrate (16 mmol/l),  potassium iodide (15 mmol/l) and copper sulphate (6 
mmol/l). 
The serum sample was mixed with the reagent solution and the mixture 
was incubated for 15 minutes at 25°C.  the absorbencies of sample (A sample) 
and standard (A standard) were read against the regent blank in a 
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spectrophotometer (Scientific Technical Supplies Spectronic 501-Germany)  at a 
wavelength of 546nm and the concentration (c) of serum total protein was 
calculated as follows: 
                 (g/dl)  =           A- sample x 8 
                                           A- standard 
Where 8 denotes concentration of standard (8mg/dl) 
 
2.2.2.1.3 Albumin  
Serum albumin concentration was determined by a colorimetric method 
using a commercial kit (Plasmatec Labs.  Products, Germany). 
Test principle  
The method is based on using bromocresol green (BCG) at pH 4.2 
Absorbencies were read at wavelength 628nm. 
                         C (mg/dl) =              A- sample  x 5 
                                                           A- standard  
Where 5 denotes concentration of standard (5mg/dl) 
 
2.2.2.1.4  Urea 
Urea concentration in serum measured  using enzymatic colorimetric 
method described by Monica (1992). 
The principle of method that urea is hydrolyzed by urease to ammonia 
and carbon dioxide. The intensity of the color formed when ammonia react with 
alkaline hypochlorite and sodium salicylate is proportional to the concentration 
of urea in serum sample.  
Urea  + H2O                2NH 3 +CO2 
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The prepared serum and reagent were placed at room temperature . The 
color intensity was measured using spectrophotometer at wave length 600 nm 
and urea concentration was calculate as follow : 
Urea (mg/dl) =     Tested sample         X   50 
                     Standard sample 
Where 50 was the standard concentration. 
 
2.2.2.1.5 Uric acid 
Serum uric acid concentration was determined by an enzymatic method 
using a kit (Arcomex, Arab Company for Medical Diagnostics , Amman, 
Jordan). 
Test principle 
Uric acid is converted by uricase to allontoin and H2O2 which under the 
catalytic effect of perioxidase (POD) oxidizes to 3,5 dichloro –2- 
hydroxybenzene sulphonic acid (3,5 DHBS) and 4- aminophenazone to form a 
red violet quinoneimine complex: 
 
Uric acid +O2 + 2H2O           uricase                allanoin + Co2 + H2O2 
2H2O2 + 3,5,DHBS + 4-A.P          POD                 quinoneimine + HCL+ ZH2O. 
 
 
Serum was mixed with buffered reagent solution and the mixture was 
incubated for 15 minutes at room temperature (or for 15 minutes at 37°C).  
Absorbencies of the sample and the standard (5 mg/dl) were read in the 
spectrophotometer against the reagent blank at wavelength of 520nm.  Uric acid 
concentration (c) was estimated in mg/dl as follows: 
(mg/dl) =               A- sample X5 
                               A- standard 
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2.2.2.1.6  Creatinine 
Serum creatinine concentration was measured by a colorimetric method 
using a commercial kit (Plasmatec Labs.  Products, Germany). 
Test principle 
The method is based on the formation of a reddish brown complex with 
picrate in alkaline medium. The rate of formation of products was measured.  
Saturated aqueous solutions of picric acid (1.4%w/v) and sodium hydroxide 
(3.0% w/v) were the main solutions used. The absorbencies of the sample (A- 
sample ) and creatinine standard (A –standard) were read in the 
spectrophotometer at a wavelength of 492nm.  Creatinine concentration was 
calculated as follows: 
              C (mg/dl) =        A- sample  x 2.5 
                                          A -standard  
 
2.2.2.1.7 Total bilirubin 
Serum total bilirubin concentration was measured by a calorimetric 
method using a commercial kit (Randox laboratories Ltd., U.K.)  
 
Test principle  
Albumin-bound bilirubin is released by a detergent and the total bilirubin 
reacts with 2, 4-di- chloroalanine to form a coloured a zobilirubin which is 
measured in the spectrophotometer at a wave length of 456 nm.  
Serum was mixed with the working reagent solution and the mixture was 
allowed to stand for 10 minutes protected from light. Absorbence of the sample 
(A sample) was measured against the sample blank and concentration (C ) of 
bilirubin was estimated as follows: 
 C (mg/dl) = A sample X 12.5 
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2.2.2.2 Serum electrolytes                
2.2.2.2.1 Sodium 
serum sodium was determined by flame-photometry (Evans Electro 
selenium Ltd., England ) as described by Varley (1967). The method is based on 
passing under controlled conditions, diluted serum (1: 100) as a very fine spray 
in the air supply to a burner where the solution evaporates and the salt 
dissociates to give neutral atoms. Light of characteristic wavelengths was 
emitted and passed through a specific filler for sodium on to a selenium cell and 
the amount of current produced was read on a galvanometer. Readings were 
recorded and values were estimated in mEq/ liter as follows: 
     Concentration (Meq/l)  =      T- sample X 140 
                                                      S- sample  
The values were then converted to mg/dl. 
 
2.2.2.2.2 Potassium 
The method described by Varley (1967) for the determination  of serum 
potassium is based on the same principle of flame-photometry for serum 
sodium.  The sensitivity of the instrument was varied in order to use the same 
dilution of serum (1:100) for both sodium and potassium.  
Light of characteristic wavelengths was emitted and passed through 
specific filter for potassium on to a selenium cell and the amount of current 
produced was measured.  
Changes in galvanometer readings were recorded and values were 
estimated in meq/l as follows: 
Concentration (Meq/l) =    T- sample   X 5 
                                           S- standard  
 
The values were there converted to mg/dl. 
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2.2.2.2.3  Phosphorus 
Serum phosphorus concentrations were determined colorimetrically 
using a commercial kit (Plasmatec Labs.  Products, Germany). 
Test principle 
The principle is based  initially on the precipitation of serum protein by 
trichloro-acetic acid.  Deproteinized serum reacts with molybdate (ammonium 
molybdate 40mmol/l ; sulphuric acid 2.5-N and vanadate ammonium vanadate 
21 mmol/1 in nitric acid ) to give a coloured complex.  The absorbance of 
sample (A- sample) was read against a blank at a wavelength  405nm 
                  C (mg/dl) =      A -sample  x 42.2 
                                              A- standard  
 
2.2.2.3  Serum enzyme activities 
2.2.2.3.1  Aspartate aminotransferase (Glutamicoxaloacetic transaminase,  
                              L, Aspartate = 2 – OXO-glutarate aminotransferase E.C.2,6, 1.1,  
                               AST). 
Serum a separate amino transferase activity was measured by the 
enzymatic reaction sequence employed by a commercial kit (Plasmatec Labs.  
Products, Germany). 
Test principle 
L-aspartate + (- oxoglutarate AST-L-Glutamate + Oxaloacetate.  AST 
activity was determined by measuring the rate of oxidation of NADH by the 
spectrophotometer (Spectronic 501, scientrific Technical supply, Karl Kolb, 
Germany)  included in the reagent to convert endogenous pyruvate in the sample 
to lactate during the lag phase prior to measurement. A unit per litre  (U/L) of 
AST activity is the amount of enzyme, which oxidize one mole of NADH per 
minute serum AST activity was calculated as follows  
U/L =    ∆ A 340/min X 1768. 
Where ∆ A 340= mean absorbance change at 340nm wavelength. 
Nimtalla, Hanan M., MVSc. Thesis, 2008 
 34 
  
 
2.2.2.3.2 Alanine amino transferase, (Glutamic pyruvic transaminase,L-  
                    aspartate,2-oxoglutamate ALT) 
      It is an enzymatic method ,which measures glutamic pyruvic transaminase 
in sera by monitoring the concentration of pyruvate hydrazone formed with 2-
4dinitrophenyl hydrazine. 
 Test principal   
                 Oxoglutarate + L-alanine       ALT          L-glutarate   +   pyruvate 
 
        The absorbance of samples were read against the reagent blank after 5 
mintues at wavelength of 630 nm UV/VIS Spectrophotometer.The ALT was 
measured in U/L. 
 
2.2.3 Histopathological  methods 
Tissue specimens collected from animals liver, kidney, heart, lung, 
spleen and intestine after dead or slaughtered were immediately fixed in 10% 
buffered formalin( sodium hydrogen 6.5 gm/L and sodium dihydrogen 4 gm/L) 
then embedded in paraffin wax, sectioned at 5µ and stained routinely with 
Haematoxylin and Eosin (H&E) using Drury and Wallington (1980) method. 
 
2.3  Statistical analysis 
           Mean values obtained in blood and serum parameters were 
statistically verified using the un-paired student t-test. All means were compared 
at the 5% propability level (Mendehall, 1971).     
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CHAPTER THREE 
RESULTS 
3.1 Clinical signs  
         Severity of symptoms in goat kids surviving both treatment and recovery 
periods with timed mortalities are shown in Table 1.  Goats received 30 mg/kg 
body weight potassium bromate showed diarrhea in goat 2, whereas dullness, 
weakness, nasal discharge, lacrimation , diarrhea and decreased appetite were 
observed in goats 7 and 9 which received the 60 mg/kg body weight potassium 
bromate. Goat 3 showed similar symptoms, but more severe and there is 
temporary partial paralysis. Recumbency, decreased urination, diarrhea, nasal 
discharge, lacrimation and decreased appetite were noticed in goats 12 and 13 
that received the 90 mg/kg body weight potassium bromate. In goat 5 symptoms 
were similar to goat 12, but there was blood tinged urine. These symptoms are 
more severe in goats 5, 12 and 13 treated with 90 mg/kg body weight potassium 
bromate.  
           The mortalities were 100% and 33.3% in goats that received the 90 and 
60 mg/kg body weight potassium bromate respectively. 
 
3.2 Body weight changes 
        Table 2 shows the effect of various doses of potassium bromate on goats 
body weight. Group D goats died before the end of the treatment period. Groups 
B and C recorded significantly (p<0.05) lower final body weights compared to 
the control in both treatment and recovery periods, with their respective             
weight gains in both periods recording significantly (p<0.05) lower values.      
    
3.3 Haematological findings 
        The haematological changes in goats kids treated with potassium bromate 
are summarized in Table 3. There were significant (p<0.01) decreases in RBCs 
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and WBCs values in all groups in the treatment period and significant (p<0.01) 
decreases in RBCs in the recovery period in groups B and C, whereas there were 
significant (p<0.01) increases in WBCs values in groups B and C in the recovery 
period.  
 
 
Table 1. Severity of symptoms and mortalities in goat kids challenged with oral 
potassium bromate for 6 weeks treatment and 4 weeks recovery periods.   
Treatment groups and dosage Recovery groups and dosage  
Symptoms A (00 
mg/kg) 
B (30 
mg/kg) 
C (60 
mg/kg) 
D (90 
mg/kg) 
A (00 
mg/kg
) 
B (30 
mg/kg) 
C (60 
mg/kg) 
D (90 
mg/ 
kg) 
 
 
Diarrhoea 
- G2 + G3 ++ 
G7 + 
G9 + 
G5 ++ 
G12 ++ 
G13 ++ 
- - - - 
Dullness - - G3 ++ 
G7 + 
G9 + 
G5 ++ 
G12 ++ 
G13 ++ 
- - - - 
Weakness - - G3 ++ 
G7 + 
G5 ++ 
G12 ++ 
- - G3+ 
 
- 
   G9+ G13++     
Nasal 
Discharge 
- - G3 + 
G7 + 
G9 + 
G5+ 
G12 + 
G13+ 
 
- 
- - - 
Decreased 
appetite 
- - G3 + 
G7 + 
G9+ 
G5 ++ 
G12 ++ 
G13 ++ 
- - - - 
Lacrimation - - G3 + 
G7 + 
G9+ 
G5+ 
G12 + 
G13+ 
- - - - 
Partial 
paralysis 
- - G3+ 
 
 - -  - 
Recumbency - - - G5 + 
G12 + 
G13 + 
- - - - 
Decreased 
Urination 
- - - G5 + 
G12 + 
G13+ 
- - - - 
Bloody 
Urine 
- - - G5 + - - - - 
Mortality 
(week) 
- - G7 
at W4 
G5 at W2 
G12 at W2 
G13 at W1 
-    
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Table 2. Average (mean ± s.d.) values of goat kids changes in body weights (kg) during 
treatment (6 wks) with, and recovery (4 wks) from oral potassium bromate. 
Period Group and dosage Initial weight 
(kg) 
Final weight 
(kg) 
Weight gain  
(kg) 
A (00 mg/kg) 12.07± 0.45  12.40 ± 00.85 00.53± 0.32 
B (30 mg/kg) 11.73± 1.00 10.63± 00.40* -01.10± 0.79* 
C (60 mg/kg) 11.87± 0.91 09.07± 01.44* -02.80± 2.33* 
 Treatm
ent      D (90mg/kg)   11.90± 0.85 - - 
     
A (00 mg/kg)  12.40 ± 00.85 14.00± 00.82  01.57± 00.15 
B (30 mg/kg) 10.63± 00.40* 10.53± 00.47* -00.10± 00.85*
C (60 mg/kg) 09.07± 01.44* 09.55± 01.91* -00.05± 00.35*
 
R
ecovery D (90mg/kg) - - - 
*Denotes mean values significant at ( p<0.05). 
 
        There were no significant (p<0.01) changes in Hb and PCV values in all 
groups in the treatment and recovery periods. There were significant (p<0.01) 
decreases in MCHC values in the treatment period in groups C and D with 
significant (p<0.01) increases in the recovery period in groups B and C. In MCV 
values there were significant (p<0.01) increases in groups C and D in the 
treatment period and also significant (p<0.01) increases in group B and C in the 
recovery period.      
WBCs differential count in goats kids treated with potassium bromate is 
summarized in Table 4. There were significant (p<0.01) decreases in 
lymphocytes values in groups C and D in the treatment phase and there was 
significant (p<0.01) increase in group B in the recovery period. Neutrophils 
values showed significant increases (p<0.01) in groups C and D in the treatment 
period, with non significant (p>0.01) changes in all groups in the recovery 
period. Monocytes values showed significant (p<0.01) decrease in group C with 
a significant (p<0.01) increase in group D in the treatment period. Oesinophils 
values showed significant (p<0.01) decrease in group C in the treatment period 
and a significant (p<0.01) increase in group C in the recovery period. 
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Table 3. Average (mean ± s.d.) blood values of goat kids during treatment (6 wks) with, 
and recovery (4 wks) from oral potassium bromate. 
 
Period Group and 
dosage 
RBCs 
×106 mm 
WBCs 
×103 mm 
Hb 
 g/dl 
PCV 
% 
MCHC 
% 
MCV 
% 
A(00mg/kg) 7.61±1.41 6.23±1.93 10.98±0.87 30.42±02.84 36.15±0.67 40.98±6.76 
B(30mg/kg) 7.31±0.97** 6.18±1.75** 10.51±0.71 29.00±02.34 36.27±0.73 40.61±6.43 
C(60mg/kg) 7.00±0.97** 5.66±1.93** 10.26±1.15 28.58±03.00 35.83±1.18** 41.88±8.55** 
    Treatm
ent 
D(90mg/kg) 6.42±1.02** 4.90±0.79** 11.32±0.89 32.00±04.55 35.48±1.99** 50.20±7.92** 
 
A(00mg/kg) 
 
7.10±0.58 
 
6.82±0.71 
 
10.23±1.40 
 
28.44±3.78 
 
35.94±1.33 
 
40.48±7.07 
B(30mg/kg) 6.96±0.66** 7.21±0.58** 10.43±0.71 27.78±3.73 36.29±0.81** 40.69±7.15** 
C(60mg/kg) 6.63±0.69** 7.40±1.71** 09.86±0.99 27.14±3.02 36.33±0.58** 41.47±8.14** 
      R
ecovery 
D(90mg/kg) - - - - - - 
Means in a column bearing no asterisks are not significantly different (p>0.05). 
** Denotes mean values significantly different at (p< 0.01). 
 
 
 
 
Table 4. Average (mean ± s.d.)  values of WBCs differentional count  of goat kids during 
treatment (6 wks) with, and recovery (4 wks) from oral potassium bromate. 
 
Period Group and 
dosage 
Lympho.% Neutro.% Mono.% Oesino.% 
A(00mg/kg) 62.17±3.43 31.50±3.68 3.50± 0.90 3.67±1.15 
B(30mg/kg) 62.17±4.84 31.33±4.16 3.42±1.16 3.08±1.44 
C(60mg/kg) 56.67±4.92** 37.50±5.25** 3.08±0.90** 2.67±0.98** 
Treatm
ent D(90mg/kg) 59.60 
±1.52** 
32.20±1.30** 4.40±0.55** 3.20±0.84 
      
A(00mg/kg) 61.78±3.19 33.78±5.36 2.78±1.09 2.78 ±1.20 
B(30mg/kg) 65.11±4.14** 31.11±4.68 2.11±0.93 2.22±0.44 
C(60mg/kg) 52.71±5.91 41.71±4.64 2.29±0.49 3.29±1.89**
 R
ecovery 
D(90mg/kg) - - - - 
Means in a column are not significantly different (p>0.05).  
** Denotes mean values significantly different at (p< 0.01). 
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      3.4 Changes in serum constituents 
        The effects of various doses of potassium bromate on the concentrations of 
serum metabolites, total protein, albumin, globulin, glucose, urea, uric acid, 
creatinine and total bilirubin are given in Table 5. There were no significant 
effects in glucose concentrations in all groups. Total protein, albumin and 
globulin concentrations showed significant (p<0.01) increase in groups B, C and 
D. 
         There were significant (p<0.01) increases in urea and creatinine 
concentrations in group D. Uric acid concentration showed significant (p<0.01) 
decreases in all groups B,C and D. Total bilirubin concentrations were not 
significantly chances.  
    Table 5. Average (mean ± s.d.) values of serum metabolites of goat kids  
treated with oral potassium bromate for 6 weeks. 
 
Group  
and dosage 
Glucose 
(mg/dl) 
Total protein  
(mg/dl) 
Albumin 
(mg/dl) 
Globulin 
(mg/dl) 
A (00mg/kg) 27.08±24.77 5.46±1.40 3.18±0.53 2.28±0.94 
B (30mg/kg) 24.67±19.51 5.74±1.21** 3.26±0.58** 2.48±0.92** 
C (60mg/kg) 27.22±19.90 6.27±1.14** 3.54±0.48** 2.70±0.72** 
D (90mg/kg) 26.00±13.34 6.70±0.91** 3.54±0.09** 3.16±0.86** 
Table 5 contd. 
Group 
 and dosage 
Urea 
(mg/dl) 
Uric acid  
(mg/dl) 
Creatinine 
(mg/dl) 
Total  bilirubin 
(mg/dl) 
A(0mg/kg) 45.00±14.80 1.03±0.40 0.61±0.23 0.08±0.07 
B(30mg/kg) 42.17±11.55 0.84±0.09** 0.64±0.29 0.12±0.07 
C(60mg/kg) 42.67±15.73 0.88±0.23** 0.56±0.11 0.06±0.07 
D(90mg/kg) 56.80±13.76** 0.88±0.84** 0.88±0.36** 0.12±0.08 
Means in a column are not significantly different (p>0.05). 
** Denotes mean values significantly different at (p< 0.01). 
 
          The effects of various doses of potassium bromate on the serum 
concentrations of sodium, potassium and phosphorus are given in Table 6. 
There were significant (p<0.01) increase in sodium concentrations in group D in 
the treatment period, whereas phosphorus concentrations showed significant 
(p<0.01) increases in all test groups in the treatment period. 
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         The effects of various doses of potassium bromate on the concentrations of 
serum enzymes are given in Table 7. There were significant (p<0.01) decreases 
in AST concentrations in group B and D, whilst AST concentration in group C 
was significantly (p<0.01) increased. In ALT serum concentrations, there were 
significant (p<0.01) increases in groups B and D, when ALT concentration in 
group C was significantly (p<0.01) decreased.  
 
 
Table 6. Average (mean ± s.d.) values of serum electrolytes of goat kids 
during treatment (6 wks) with, and recovery (4 wks) from oral potassium bromate. 
Period Group 
 and  dosage 
Na  
(mg/dl) 
K 
 (mg/dl) 
PO4 
 (mg/dl) 
A (0 mg/kg) 142.33±16.58 4.90 ± 0.62 06.51± 1.91 
B (30 mg/kg) 126.66± 41.15 5.39 ± 0.75 08.39±1.12** 
C (60 mg/kg) 124.50± 23.70 4.45 ± 0.59 10.00± 4.33** 
Treatm
ent D. (90mg/kg) 149.20±27.62** 3.45± 1.83 07.74 ± 1.29** 
     
A (0 mg/kg) 134.67± 07.30 5.13 ± 0.69 - 
B (30 mg/kg) 110.89± 38.00 5.06 ± 0.66 - 
C (60 mg/kg) 120.43 ± 28.26 4.57 ± 0.79 - 
R
ecovery D. (90mg/kg) - - - 
Means in a column are not significantly different (p>0.05). 
 ** Denotes mean values significantly different at (p< 0.01). 
 
 
Table 7. Average ( mean ± s.d. ) values of serum enzymes of  goat kids treated with oral 
potassium bromate for 6 weeks. 
 
Group 
and dosage  
AST 
I.U 
ALT 
I.U 
A(0mg/kg) 172.58± 164.77 31.13±16.50 
B  (30 mg/kg) 157.42± 142.91** 40.29±16.47** 
C  (60 mg/kg) 186.56± 188.01** 22.61±06.95** 
D  (90 mg/kg) 151.40±097.80** 33.58 ±15.15** 
 Means in a column are not significantly different (p>0.05).  
** Denotes mean values significantly different at (p< 0.01). 
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3.5 Post mortem findings 
          Group D which is treated with 90 mg/kg body weight potassium bromate 
showed congested intestine (Figure 1), fatty degeneration and congestion in the 
kidney with the liver congested and fatty degenerated. Goat 12 of this group 
showed enlargement of gall bladder (Figure 2).    
         Tissue lesions in group C which was treated with 60 mg/kg boy weight 
potassium bromate were congestion and fatty degeneration in both kidney 
(Figure 3) and liver.  
There was no post mortem changes seen in group B witch is treated with 30 
mg/kg body weight potassium bromate.  
 
 
Figure 1. Congested  intestine opf goat kid 12 
treated with 90mg/kg body weight potassium 
bromate. 
 
 
 
 
Figure 2. Congested liver and enlargement in 
the gall bladder of goat kid 12 treated with 
90mg/kg body weight potassium bromate. 
 
 
 
 
 
Figure 3. Congestion and fatty degeneration in 
the kidney of goat kid 7 treated with 60mg/kg 
body weight potassium bromate. 
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3.6 Histopathological findings 
             In the group of goats treated with 90mg potassium bromate/kg body 
weight, the liver of goat 13 showed hepatocytic degeneration and necrosis. 
Necrotic areas are showing telangiectatic dilatations filled with blood. There is 
widening of portal vessels and peripheral hepatocytes stain more eosinophilic 
(Figure 4). Liver of goat 5 showed hypatocyte necrosis and spaces filled with 
lymphocytes. Kidney at this dose level of gaot 13 showed dilated urinary spaces 
with many glomeruli showing lobulated tufts, congestion and swelling of tubular 
cells around the glomeruli and desquamation of tubular epithelia (Figure 5), 
whereas in the kidney of goat 12, tufts show hypercellularity and also there was 
desquamation of the tubular epithelia. Kidney of goat 5 showed glomeruli with 
compact tuft lobulation. There were marked congestion in the lung in all of the 
goats in this group, with goat 5 showing additionally some areas of mononucular 
cells infilteration and many alveoli show exudates with thickened interlobular 
septa (Figure 6). 
 
 
Figure 4. Hepatocyte degeneration, necrosis 
ad widening  of portal vessels in the liver of 
goat kid 13 treated with 90mg/kg body weight 
potassium bromate.  H&E x100. 
 
 
 
 
 
Figure 5. Dilated urinary spaces, congestion, 
swelling of tubular cell and desquamation of 
tubular epithelia in the kidney of goat kid 13 
treated with 90mg/kg body weight potassium 
bromate.   H&E x100. 
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Figure 6. Congestion, mononucular cell 
infilteration and thickened interlobular 
septum in the lung of goat kid 5 treated with 
90mg/kg body weight potassium bromate. 
H&E x 100. 
 
 
 
           In the group treated with 60mg/kg body weight potassium bromate, the 
liver of goat 3 showed cellular swelling and that of goat 9 showed in addition 
focal lymphocyte infilteration in parenchyma and portal areas (Figure 7). The 
kidney of goat 3 showed swelling of the cortical tubules, hypercellularity of 
glomerular tufts and dilated tubules especially distal tubules (Figure 8), whereas 
in the kidney of goats 7 and 9  only hypercellularity of glomerular tufts appeared 
with dilated urinary space only seen in goat 7. Distinct trabeculations, loose but 
wide white pulp and marked hemosiderosis in the red pulp were seen in the 
spleen of goat 3 (Figure 9). In the spleen of goat 7 there was marked 
trabeculations and small white pulp. The spleen of goat 9 showed distinct white 
pulp with germinal centers and hemosiderosis.    
 
 
 
Figure 7. Cellular swelling and focal 
lymphocyte infilteration in the liver of goat 
kid 9 treated with 60mg/kg body weight 
potassium bromate. H&E x 100. 
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Figure 8. Swelling of cortical tubules, 
hypercellularity of glomerular tufts and 
dilated tubules in the kidney of goat kid 3 
treated with 60mg/kg body weight potassium 
bromate. H&E x 100. 
 
 
 
 
 
Figure 9. Distinct trabeculations, wide white 
pulp and marked hemosiderosis in the red 
pulp in the spleen of goat kid 3 treated with 
60mg/kg body weight potassium bromate. 
H&E x 100. 
 
 
 
          In the group treated with 30mg/kg body weight potassium bromate, the 
liver of goat 14 showed hepatocyte swelling with irregular cytoplasmic 
vaculations i.e. heydropic degeneration (Figure 10). The liver of goat 2 showed 
similar lesions to goat 14. Liver of goat 6 showed widened central vein and 
portal vessels, cell swelling and irregular cytoplasmic vaculations. Some dilated 
vessels contain large round clumps mainly lymphocytes and some portal areas 
show lymphocyte infilteration, (Figure 11). The kidney of goat 14 showed 
dilated tubules with expanded tufts almost filling the glumeruli, and in the 
kidney of goat 2 the glumeruli appear with compact tuft but normal urinary 
space.  
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Figure 10. Hepatocyte swelling and irregular 
cytoplasmic vaculations in the liver of goat 
kid 14 treated with 30mg/kg body weight 
potassium bromate.   H&E x 100. 
 
 
 
 
 
 
 
Figure 11. Hepatocyte with irregular 
cytoplasmic vaculations and widened central 
vein and portal vessels with clumps (mainly 
lymphocyte) in the liver of goat kid 6 treated 
with 30mg/kg body weight potassium 
bromate. H&E x 100. 
 
 
 
 
The spleen of goat 14 showed prominent red pulp with germinal centers (Figure 
12) and the spleen of goat 6 showed lymphoid hyperplasia, prominent germinal 
centers in the white pulp (Figure 13), whereas the spleen of goat 2 show distinct 
white pulp with fairly visible germinal centers. The intestine of goat 2 showed 
tapered villi and elongated glands. Lamina propria was stuffed with cells of red 
cytoplasmic granules. The submucosa was odematous (Figure 14).  
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Figure 12. Prominent red pulp with germinal 
centers in the spleen of goat kid 14 treated 
with 30mg/kg body weight potassium 
bromate.  H&E x 100. 
 
 
 
 
 
 
 
 
 
 
Figure 13. Lymphoid hyperplasia and 
prominent germinal centers in the white 
pulp in the spleen of goat kid 6 treated with 
30mg/kg body weight potassium bromate.   
H&E x100. 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Tapered villi, elongated gland, 
lamina propria stuffed with cells and odema 
in submucosa in the intestine of goat kid 2 
treated with 30mg/kg body weight 
potassium bromate.    H&E x 100. 
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CHAPTER FOUR 
DISCUSSION 
              Potassium Bromate, a synthetic halide compound (DHSS, 2005 and 
E.G.V.M, 2002) was classically used as an oxidizing agent and food additive 
especially in flour milling, beer malting and cheese making before 90 years. 
Potassium bromate may be fatal if swallowed, harmful if inhaled or absorbed 
through the skin. It causes irritation to skin, eyes, gastrointestinal tract and the 
respiratory tract and may cause kidney damage.  Repeated exposure may affect 
the nervous system (E.H.S., 2004). The carcinogenicity of potassium bromate 
has been investigated widely and has yielded equivocal results (De Angelo et 
al.,1998;   Matsushima et al., 1986; Ishidate et al.,1980; Hayashi et al,1988). 
         The present study has shown that oral potassium bromate has effected 
toxic manifestation in Nubian goat kids at doses 30, 60 and 90mg/kg body 
weight. At the dose level 30mg/kg body weigh, potassium bromate imposed 
mild or no clinical signs or mortalities in goat kids. Doses of 50 mg/kg body 
weight were not reported toxic in rats (Abd Ehalim, 2006). Higher doses 60-90 
mg/kg body weight has inflicted distinct clinical signs and high mortalities. 
Signs of diarrhea, lacrimation, weakness, nasal discharge, urination and 
frequently bloody urine with potassium bromate challenge were reported also by 
Kurokawa et al., (1990) in mice and hamsters. The pathological changes in 
lung, intestine and kidney correlate the appearance of these clinical signs. 
        There were significant effects on the body weights in goat kids dosed with 
potassium bromate. Where the dose of 90mg/kg body weight is detrimental        
(mortal), in the other two doses (30-60mg/kg body weight) goats significantly 
lost body weights. Oral dosing of the toxicant may exert its effect on the ruminal 
microflora and microfauna thus affecting the microbial digestion and 
consequently energy and protein substrates. Hence, oral potassium bromate 
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retards the growth rate of small ruminants (goats). Kurokawa et al., (1983, 
1986a and 1990) and DeAngelo et al., (1998) reported a significant decrease in 
the body weight in rats, similar to  Kawana et al., (1991) who reported 
significant decrease in body weight in mice. Conversely, Farombi et al., (2002) 
in rats and DeAngelo et al., (1998) in mice reported no effect on the body 
weight. 
          There were significant decreases in RBCs and WBCs values in all test 
groups in the treatment period. This decline in RBCs points towards anaemia. 
The lowered RBCs values and leucocytopenia were observed also in rats fed 
oral potassium bromate at 150 mg/kg per day (Abdel Gadir et al., 2007). 
Whether potassium bromate has retarding effect on haemopoeisis is not 
confirmed as yet. The Hb concentration showed no significant changes during 
the treatment or recovery periods in all treatment groups, with tendency to 
elevate in group D during the treatment period. Potassium bromate usually 
encounters high met Hb (Chipman et al., 1998 and Watanabe et al., 2002) 
according to the dose concentration. Abd Elhalim (2006) in rats noticed a 
transient decrease in Hb and PCV at the dose of 200 mg potassium bromate /kg 
body weight. The trend increase in MCV values with the increase in bromate 
dose was the result of a decrease of total blood cell counts at normal PCV 
values. Hence, indication is for macrocytic normochromic anemia. The values of 
the decreasing MCHC can effectively recover to normal concentrations on 
bromate withdrawal. The differential profile of the white cells revealed values 
within the normal ranges. Variability towards higher or lower values existed 
mostly with the higher bromate doses (60-90 mg/kg). These variabilities 
disappear mostly on recovery indicating reversibility of the toxic effect. 
Irregularities may be due to the known toxin effect on the bone marrow (Ref), 
decreasing on lymphocytes and increasing on neutrophils, a status known as 
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stress neutrophilia which was noted by Jain (1986) in domestic animals. 
Neutropenia is observed in infections such as bacterial (typhoid) viral (measles  
 
influenza etc.) and in other conditions such as anemias (aplastic, megaloblastic, 
iron deficiency) and in suppression of bone marrow by various drugs and 
radiation.  
               There was no significant effect on successively increasing doses of 
potassium bromate on blood glucose. Ruminants can do with less glucose 
compared to monogastric animals, as alternative energy sources (volatile short 
chain fatty acids) usually exist (Blaxter, 1967).  The increases of Total protein, 
albumin and globulin in groups B, C and D may be due to effects of potassium 
bromate on bone marrow cells. Fujie et al. (1988) and Hayashi et al. (1988) 
reported significant cytogenic effects on femoral bone marrow in rats and mice. 
Effects on bone marrow can also create a paraproteinaemia, hence total protein 
increases were not all attributed to liver synthesis. The known toxic effects of 
the bromate on the kidney (Kurokawa et al., 1990; Watanabe et al., 2002; 
Okalie and Ikewuchi, 2004 and Abd Elhalim 2006) revealed significant 
increases in creatinine and urea at the highest dose of group D (90mg/kg body 
weight) augmented with the pathological changes seen in the kidney. Uric acid 
level was significantly decreased on bromate dosing, being an intermediary 
protein catabolism metabolite, in pathway to urea for final excretion in urine. 
The pathological changes seen in the kidney seem insufficient to bring about 
significant changes in bilirubin levels at all bromate doses and likewise ALT and 
AST values were irregular subject to the extent of cellular damage. Kurokawa 
et al. (1990) in rats dosed with potassium bromate, found an increase in sodium, 
ALT and AST and a decrease in potassium values, whereas Abd Elhalim 
(2006) in rats also dosed with potassium bromate, found similar results with the  
enzymes with an increase in potassium and a decrease in sodium values. 
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Potassium bromate imposes irregularities on the kidney in the glomerular 
filteration, reflected on electrolytes secretion due to defective membrane  
 
permeability. In this study significant increases were seen with phosphates and 
an increase in sodium was dose dependant at 90 mg /kg, whilst potassium 
showed no significant changes. Controversial findings in the levels of sodium 
and potassium subject to doses and species were recorded (Kurokawa et al., 
1990 and Abd Elhalim, 2006). Withdrawal of the bromate in the recovery 
period seemed to return the electrolytes levels back to normal. Lung congestions 
found were similar to those found by Kurokawa et al. (1990) in mice and 
hamster. Dilatation and desquamation of tubules and other histopathological 
changes are indicative of potassium bromate kidney damage effects en route of 
excertion in mice, hamsters and rats (Kurokawa et al., 1990) and in rats 
(Kurokawa et al., 1983; Nakano et al., 1989; Kurata et al., 1992 and De 
Angelo et al., 1998).           
 
 
Conclusions 
• The toxicity of potassium bromate in Nubian goat kids is well defined at 
the dose level of 90 mg/kg body weight in haematological, serum 
parameters and histopathological picture.  
• Dose dependence is manifested on increasing intensity of symptoms and 
blood and serum values on increasing the dosage from 30 to 60 mg/kg 
body weight.  
• Histopathological changes were evident in vital organs at doses 30 to 60 
mg/kg body weight but were not sufficient to impose haematological or 
serum parameters significant changes.  
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Suggestions for future work 
• Higher dose ranges are needed to confirm and reveal other toxicity 
profiles of potassium bromate. 
 
• Longer exposure studies to potassium bromate at different dose levels 
should reveal the tolerance to the toxicant.  
• More studies with other animal species are needed at varied dose rates and 
time exposures to report species differences.  
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APPENDIX  I 
 
POTASSIUM BROMATE 
PHYSICAL AND CHEMICAL PROPERTIES 
 
 
Chemical Abstracts Service No :- 7758-01-2 
Registry of toxic Effects of Chemical Substance No :-  EF8725000  
Synonyms :- Bromic acid, Potassium salt 
Molecular formula :-KBrO3 
Molecular weight :- 167.01 
Appearance :- odorless, tasteless, and white powder or crystals 
Melting point :- 350 C  
Boiling point :- decomposes at 370 C 
Density  :- 3.27 g/m3 
Solubility in water :- 133 g/L at 40 C. slightly soluble in alcohol, insoluble in ether 
                                                                             (Sax and lewis, 1989; Weast, 1985). 
 
 
Specific Gravity :- 3.27 
Vapor Density  (Air =1) :- 5.8 
Hazard class :- 5.1 
Hazard rating :-  2  
Flammability rating :-  0 
Reactivity rating :-  0 
                                  (E.H.S, 2004). 
 
